{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:51Z","timestamp":1791412071219,"version":"4.3.3"},"reference-count":294,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s12016-016-8552-9","type":"journal-article","created":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T09:26:20Z","timestamp":1463736380000},"page":"234-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis"],"prefix":"10.1007","volume":"52","author":[{"given":"Alexandre T. J.","family":"Maria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Maumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Le Quellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"issue":"2","key":"8552_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.autrev.2010.08.011","volume":"10","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Mazzone T (2010) Human cord blood stem cells and the journey to a cure for type 1 diabetes. Autoimmun Rev 10(2):103\u2013107. doi: 10.1016\/j.autrev.2010.08.011","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8552_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.autrev.2011.01.005","volume":"10","author":"E Ben-Ami","year":"2011","unstructured":"Ben-Ami E, Berrih-Aknin S, Miller A (2011) Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev 10(7):410\u2013415. doi: 10.1016\/j.autrev.2011.01.005","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8552_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","volume":"12","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Carubbi F, Liakouli V, Marrelli A, Perricone C, Perricone R, Alesse E, Giacomelli R (2013) Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy. Autoimmun Rev 12(7):709\u2013716. doi: 10.1016\/j.autrev.2012.10.004","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8552_CR4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jcyt.2014.12.006","volume":"17","author":"P Cipriani","year":"2015","unstructured":"Cipriani P, Ruscitti P, Di Benedetto P, Carubbi F, Liakouli V, Berardicurti O, Ciccia F, Triolo G, Giacomelli R (2015) Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. Cytotherapy 17(7):832\u2013849. doi: 10.1016\/j.jcyt.2014.12.006","journal-title":"Cytotherapy"},{"issue":"5","key":"8552_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.autrev.2011.02.005","volume":"10","author":"C Chighizola","year":"2011","unstructured":"Chighizola C, Shoenfeld Y, Meroni PL (2011) Systemic sclerosis. Introduction. Autoimmun Rev 10(5):239\u2013240. doi: 10.1016\/j.autrev.2011.02.005","journal-title":"Autoimmun Rev"},{"key":"8552_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.01.007","author":"AC Desbois","year":"2016","unstructured":"Desbois AC, Cacoub P (2016) Systemic sclerosis: an update in 2016. Autoimmun Rev. doi: 10.1016\/j.autrev.2016.01.007","journal-title":"Autoimmun Rev"},{"key":"8552_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13075-015-0819-7","volume":"17","author":"A Cras","year":"2015","unstructured":"Cras A, Farge D, Carmoi T, Lataillade JJ, Wang DD, Sun L (2015) Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Res Ther 17:301. doi: 10.1186\/s13075-015-0819-7","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"8552_CR8","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4(5):267\u2013274","journal-title":"Exp Hematol"},{"issue":"6","key":"8552_CR9","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/stem.1681","volume":"32","author":"FJ Lv","year":"2014","unstructured":"Lv FJ, Tuan RS, Cheung KM, Leung VY (2014) Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 32(6):1408\u20131419. doi: 10.1002\/stem.1681","journal-title":"Stem Cells"},{"issue":"4","key":"8552_CR10","first-page":"557","volume":"16","author":"HM Lazarus","year":"1995","unstructured":"Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16(4):557\u2013564","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"8552_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A, International Society for Cellular T (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7(5):393\u2013395. doi: 10.1080\/14653240500319234","journal-title":"Cytotherapy"},{"issue":"4","key":"8552_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315\u2013317. doi: 10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"issue":"10","key":"8552_CR13","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10):3499\u20133506. doi: 10.1182\/blood-2007-02-069716","journal-title":"Blood"},{"issue":"9","key":"8552_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ijo.2010.269","volume":"35","author":"M Maumus","year":"2011","unstructured":"Maumus M, Peyrafitte JA, D\u2019Angelo R, Fournier-Wirth C, Bouloumie A, Casteilla L, Sengenes C, Bourin P (2011) Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes 35(9):1141\u20131153. doi: 10.1038\/ijo.2010.269","journal-title":"Int J Obes"},{"issue":"2","key":"8552_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.yexcr.2003.12.030","volume":"295","author":"P Tropel","year":"2004","unstructured":"Tropel P, Noel D, Platet N, Legrand P, Benabid AL, Berger F (2004) Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295(2):395\u2013406. doi: 10.1016\/j.yexcr.2003.12.030","journal-title":"Exp Cell Res"},{"issue":"6","key":"8552_CR16","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/stem.1982","volume":"33","author":"RM Samsonraj","year":"2015","unstructured":"Samsonraj RM, Rai B, Sathiyanathan P, Puan KJ, Rotzschke O, Hui JH, Raghunath M, Stanton LW, Nurcombe V, Cool SM (2015) Establishing criteria for human mesenchymal stem cell potency. Stem Cells 33(6):1878\u20131891. doi: 10.1002\/stem.1982","journal-title":"Stem Cells"},{"issue":"2","key":"8552_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","volume":"18","author":"J Galipeau","year":"2016","unstructured":"Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L (2016) International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy 18(2):151\u2013159. doi: 10.1016\/j.jcyt.2015.11.008","journal-title":"Cytotherapy"},{"issue":"1","key":"8552_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcyt.2012.10.008","volume":"15","author":"CA Bravery","year":"2013","unstructured":"Bravery CA, Carmen J, Fong T, Oprea W, Hoogendoorn KH, Woda J, Burger SR, Rowley JA, Bonyhadi ML, Van\u2019t Hof W (2013) Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy 15(1):9\u201319. doi: 10.1016\/j.jcyt.2012.10.008","journal-title":"Cytotherapy"},{"issue":"12","key":"8552_CR19","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1089\/scd.2012.0594","volume":"22","author":"C Menard","year":"2013","unstructured":"Menard C, Pacelli L, Bassi G, Dulong J, Bifari F, Bezier I, Zanoncello J, Ricciardi M, Latour M, Bourin P, Schrezenmeier H, Sensebe L, Tarte K, Krampera M (2013) Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. Stem Cells Dev 22(12):1789\u20131801. doi: 10.1089\/scd.2012.0594","journal-title":"Stem Cells Dev"},{"issue":"2","key":"8552_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","volume":"14","author":"M Mendicino","year":"2014","unstructured":"Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR (2014) MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 14(2):141\u2013145. doi: 10.1016\/j.stem.2014.01.013","journal-title":"Cell Stem Cell"},{"issue":"3","key":"8552_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/scrt217","volume":"4","author":"L Sensebe","year":"2013","unstructured":"Sensebe L, Gadelorge M, Fleury-Cappellesso S (2013) Production of mesenchymal stromal\/stem cells according to good manufacturing practices: a review. Stem Cell Res Ther 4(3):66. doi: 10.1186\/scrt217","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"8552_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30(1):42\u201348","journal-title":"Exp Hematol"},{"issue":"8","key":"8552_CR23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0301-472X(00)00482-3","volume":"28","author":"RJ Deans","year":"2000","unstructured":"Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28(8):875\u2013884","journal-title":"Exp Hematol"},{"issue":"1","key":"8552_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/scrt2","volume":"1","author":"S Ghannam","year":"2010","unstructured":"Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D (2010) Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 1(1):2. doi: 10.1186\/scrt2","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"8552_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jcyt.2013.02.010","volume":"15","author":"M Krampera","year":"2013","unstructured":"Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L, Therapy MSCCotISfC (2013) Immunological characterization of multipotent mesenchymal stromal cells\u2014the International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 15(9):1054\u20131061. doi: 10.1016\/j.jcyt.2013.02.010","journal-title":"Cytotherapy"},{"issue":"4","key":"8552_CR26","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM (2010) A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 5(4):e10088. doi: 10.1371\/journal.pone.0010088","journal-title":"PLoS One"},{"issue":"2","key":"8552_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaut.2009.01.003","volume":"32","author":"MG Solari","year":"2009","unstructured":"Solari MG, Srinivasan S, Boumaza I, Unadkat J, Harb G, Garcia-Ocana A, Feili-Hariri M (2009) Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J Autoimmun 32(2):116\u2013124. doi: 10.1016\/j.jaut.2009.01.003","journal-title":"J Autoimmun"},{"issue":"2","key":"8552_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2(2):141\u2013150. doi: 10.1016\/j.stem.2007.11.014","journal-title":"Cell Stem Cell"},{"issue":"7","key":"8552_CR29","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1080\/10428190701361869","volume":"48","author":"D Noel","year":"2007","unstructured":"Noel D, Djouad F, Bouffi C, Mrugala D, Jorgensen C (2007) Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 48(7):1283\u20131289. doi: 10.1080\/10428190701361869","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"8552_CR30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/sj.gt.3302019","volume":"10","author":"C Jorgensen","year":"2003","unstructured":"Jorgensen C, Djouad F, Apparailly F, Noel D (2003) Engineering mesenchymal stem cells for immunotherapy. Gene Ther 10(10):928\u2013931. doi: 10.1038\/sj.gt.3302019","journal-title":"Gene Ther"},{"issue":"3","key":"8552_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM (2014) Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32(3):252\u2013260. doi: 10.1038\/nbt.2816","journal-title":"Nat Biotechnol"},{"issue":"4","key":"8552_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/leu.2010.310","volume":"25","author":"R Meisel","year":"2011","unstructured":"Meisel R, Brockers S, Heseler K, Degistirici O, Bulle H, Woite C, Stuhlsatz S, Schwippert W, Jager M, Sorg R, Henschler R, Seissler J, Dilloo D, Daubener W (2011) Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 25(4):648\u2013654. doi: 10.1038\/leu.2010.310","journal-title":"Leukemia"},{"issue":"12","key":"8552_CR33","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103(12):4619\u20134621. doi: 10.1182\/blood-2003-11-3909","journal-title":"Blood"},{"issue":"7","key":"8552_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","volume":"5","author":"F Djouad","year":"2009","unstructured":"Djouad F, Bouffi C, Ghannam S, Noel D, Jorgensen C (2009) Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 5(7):392\u2013399. doi: 10.1038\/nrrheum.2009.104","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8552_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15(1):42\u201349. doi: 10.1038\/nm.1905","journal-title":"Nat Med"},{"issue":"12","key":"8552_CR36","doi-asserted-by":"publisher","first-page":"e14247","DOI":"10.1371\/journal.pone.0014247","volume":"5","author":"C Bouffi","year":"2010","unstructured":"Bouffi C, Bony C, Courties G, Jorgensen C, Noel D (2010) IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 5(12):e14247. doi: 10.1371\/journal.pone.0014247","journal-title":"PLoS One"},{"key":"8552_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2254","author":"P Luz-Crawford","year":"2015","unstructured":"Luz-Crawford P, Djouad F, Toupet K, Bony C, Franquesa M, Hoogduijn MJ, Jorgensen C, Noel D (2015) Mesenchymal stem cell-derived IL1RA promotes macrophage polarization and inhibits B cell differentiation. Stem Cells. doi: 10.1002\/stem.2254","journal-title":"Stem Cells"},{"key":"8552_CR38","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0179","author":"F Ke","year":"2016","unstructured":"Ke F, Zhang L, Liu Z, Yan S, Xu Z, Bai J, Zhu H, Lou F, Cai W, Sun Y, Gao Y, Wang H, Wang H (2016) Soluble tumor necrosis factor receptor 1 Released by skin-derived mesenchymal stem cells is critical for inhibiting Th17 cell differentiation. Stem Cells Transl Med. doi: 10.5966\/sctm.2015-0179","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"8552_CR39","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/art.39069","volume":"67","author":"P Luz-Crawford","year":"2015","unstructured":"Luz-Crawford P, Tejedor G, Mausset-Bonnefont AL, Beaulieu E, Morand EF, Jorgensen C, Noel D, Djouad F (2015) Glucocorticoid-induced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis. Arthritis Rheum 67(6):1514\u20131524. doi: 10.1002\/art.39069","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8552_CR40","doi-asserted-by":"publisher","first-page":"e45272","DOI":"10.1371\/journal.pone.0045272","volume":"7","author":"P Luz-Crawford","year":"2012","unstructured":"Luz-Crawford P, Noel D, Fernandez X, Khoury M, Figueroa F, Carrion F, Jorgensen C, Djouad F (2012) Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. PLoS One 7(9):e45272. doi: 10.1371\/journal.pone.0045272","journal-title":"PLoS One"},{"issue":"3","key":"8552_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford P, Kurte M, Bravo-Alegria J, Contreras R, Nova-Lamperti E, Tejedor G, Noel D, Jorgensen C, Figueroa F, Djouad F, Carrion F (2013) Mesenchymal stem cells generate a CD4\u2009+\u2009CD25\u2009+\u2009Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4(3):65. doi: 10.1186\/scrt216","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"8552_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","volume":"24","author":"PA Sotiropoulou","year":"2006","unstructured":"Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24(1):74\u201385. doi: 10.1634\/stemcells.2004-0359","journal-title":"Stem Cells"},{"issue":"1","key":"8552_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107(1):367\u2013372. doi: 10.1182\/blood-2005-07-2657","journal-title":"Blood"},{"issue":"1","key":"8552_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/scd.2014.0155","volume":"24","author":"MM Rosado","year":"2015","unstructured":"Rosado MM, Bernardo ME, Scarsella M, Conforti A, Giorda E, Biagini S, Cascioli S, Rossi F, Guzzo I, Vivarelli M, Dello Strologo L, Emma F, Locatelli F, Carsetti R (2015) Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. Stem Cells Dev 24(1):93\u2013103. doi: 10.1089\/scd.2014.0155","journal-title":"Stem Cells Dev"},{"issue":"8","key":"8552_CR45","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","volume":"25","author":"F Djouad","year":"2007","unstructured":"Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noel D (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25(8):2025\u20132032. doi: 10.1634\/stemcells.2006-0548","journal-title":"Stem Cells"},{"issue":"10","key":"8552_CR46","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"XX Jiang","year":"2005","unstructured":"Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105(10):4120\u20134126. doi: 10.1182\/blood-2004-02-0586","journal-title":"Blood"},{"issue":"2","key":"8552_CR47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcyt.2015.10.011","volume":"18","author":"M Najar","year":"2016","unstructured":"Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L (2016) Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells. Cytotherapy 18(2):160\u2013171. doi: 10.1016\/j.jcyt.2015.10.011","journal-title":"Cytotherapy"},{"issue":"10","key":"8552_CR48","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","volume":"102","author":"F Djouad","year":"2003","unstructured":"Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen C (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102(10):3837\u20133844. doi: 10.1182\/blood-2003-04-1193","journal-title":"Blood"},{"key":"8552_CR49","doi-asserted-by":"publisher","first-page":"496218","DOI":"10.1155\/2013\/496218","volume":"2013","author":"DM Patel","year":"2013","unstructured":"Patel DM, Shah J, Srivastava AS (2013) Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int 2013:496218. doi: 10.1155\/2013\/496218","journal-title":"Stem Cells Int"},{"issue":"1","key":"8552_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/wsbm.26","volume":"1","author":"NS Hwang","year":"2009","unstructured":"Hwang NS, Zhang C, Hwang YS, Varghese S (2009) Mesenchymal stem cell differentiation and roles in regenerative medicine. Wiley Interdiscip Rev Syst Biol Med 1(1):97\u2013106. doi: 10.1002\/wsbm.26","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"14","key":"8552_CR51","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1073\/pnas.1432929100","volume":"100","author":"LA Ortiz","year":"2003","unstructured":"Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100(14):8407\u20138411. doi: 10.1073\/pnas.1432929100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"8552_CR52","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.transproceed.2008.01.080","volume":"40","author":"F Zhao","year":"2008","unstructured":"Zhao F, Zhang YF, Liu YG, Zhou JJ, Li ZK, Wu CG, Qi HW (2008) Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc 40(5):1700\u20131705. doi: 10.1016\/j.transproceed.2008.01.080","journal-title":"Transplant Proc"},{"issue":"8","key":"8552_CR53","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1634\/stemcells.2005-0609","volume":"24","author":"AP Croft","year":"2006","unstructured":"Croft AP, Przyborski SA (2006) Formation of neurons by non-neural adult stem cells: potential mechanism implicates an artifact of growth in culture. Stem Cells 24(8):1841\u20131851. doi: 10.1634\/stemcells.2005-0609","journal-title":"Stem Cells"},{"issue":"7","key":"8552_CR54","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/stem.1118","volume":"30","author":"L Bahr von","year":"2012","unstructured":"von Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg B, Uzunel M, Ringden O, Le Blanc K (2012) Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells 30(7):1575\u20131578. doi: 10.1002\/stem.1118","journal-title":"Stem Cells"},{"issue":"3","key":"8552_CR55","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/mmr.2014.2981","volume":"11","author":"K Huang","year":"2015","unstructured":"Huang K, Kang X, Wang X, Wu S, Xiao J, Li Z, Wu X, Zhang W (2015) Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats. Mol Med Rep 11(3):1685\u20131692. doi: 10.3892\/mmr.2014.2981","journal-title":"Mol Med Rep"},{"issue":"2","key":"8552_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/eurheartj\/ehm559","volume":"29","author":"SM Hashemi","year":"2008","unstructured":"Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, Young R, Rippy MK, Virmani R, Litt H, Wilensky RL (2008) A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 29(2):251\u2013259. doi: 10.1093\/eurheartj\/ehm559","journal-title":"Eur Heart J"},{"issue":"4","key":"8552_CR57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1039\/c4bm00433g","volume":"3","author":"A Leroy","year":"2015","unstructured":"Leroy A, Nottelet B, Bony C, Pinese C, Charlot B, Garric X, Noel D, Coudane J (2015) PLA-poloxamer\/poloxamine copolymers for ligament tissue engineering: sound macromolecular design for degradable scaffolds and MSC differentiation. Biomater Sci 3(4):617\u2013626. doi: 10.1039\/c4bm00433g","journal-title":"Biomater Sci"},{"issue":"25","key":"8552_CR58","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1016\/j.biomaterials.2010.05.013","volume":"31","author":"C Bouffi","year":"2010","unstructured":"Bouffi C, Thomas O, Bony C, Giteau A, Venier-Julienne MC, Jorgensen C, Montero-Menei C, Noel D (2010) The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials 31(25):6485\u20136493. doi: 10.1016\/j.biomaterials.2010.05.013","journal-title":"Biomaterials"},{"issue":"5","key":"8552_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.copbio.2004.08.003","volume":"15","author":"C Jorgensen","year":"2004","unstructured":"Jorgensen C, Gordeladze J, Noel D (2004) Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 15(5):406\u2013410. doi: 10.1016\/j.copbio.2004.08.003","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"8552_CR60","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/157488809789649205","volume":"4","author":"C Vinatier","year":"2009","unstructured":"Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, Weiss P, Guicheux J, Noel D (2009) Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther 4(4):318\u2013329","journal-title":"Curr Stem Cell Res Ther"},{"key":"8552_CR61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.22203\/eCM.v028a07","volume":"28","author":"M Mathieu","year":"2014","unstructured":"Mathieu M, Vigier S, Labour MN, Jorgensen C, Belamie E, Noel D (2014) Induction of mesenchymal stem cell differentiation and cartilage formation by cross-linker-free collagen microspheres. Eur Cell Mater 28:82\u201396, discussion 96\u201387","journal-title":"Eur Cell Mater"},{"issue":"1","key":"8552_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jconrel.2013.04.017","volume":"170","author":"M Morille","year":"2013","unstructured":"Morille M, Van-Thanh T, Garric X, Cayon J, Coudane J, Noel D, Venier-Julienne MC, Montero-Menei CN (2013) New PLGA-P188-PLGA matrix enhances TGF-beta3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells. J Control Release 170(1):99\u2013110. doi: 10.1016\/j.jconrel.2013.04.017","journal-title":"J Control Release"},{"issue":"3","key":"8552_CR63","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1159\/000369742","volume":"35","author":"S Portron","year":"2015","unstructured":"Portron S, Hivernaud V, Merceron C, Lesoeur J, Masson M, Gauthier O, Vinatier C, Beck L, Guicheux J (2015) Inverse regulation of early and late chondrogenic differentiation by oxygen tension provides cues for stem cell-based cartilage tissue engineering. Cell Physiol Biochem 35(3):841\u2013857. doi: 10.1159\/000369742","journal-title":"Cell Physiol Biochem"},{"key":"8552_CR64","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2147\/IJN.S72670","volume":"10","author":"S Eap","year":"2015","unstructured":"Eap S, Keller L, Schiavi J, Huck O, Jacomine L, Fioretti F, Gauthier C, Sebastian V, Schwinte P, Benkirane-Jessel N (2015) A living thick nanofibrous implant bifunctionalized with active growth factor and stem cells for bone regeneration. Int J Nanomedicine 10:1061\u20131075. doi: 10.2147\/IJN.S72670","journal-title":"Int J Nanomedicine"},{"key":"8552_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biomaterials.2016.01.048","volume":"85","author":"IG Kim","year":"2016","unstructured":"Kim IG, Ko J, Lee HR, Do SH, Park K (2016) Mesenchymal cells condensation-inducible mesh scaffolds for cartilage tissue engineering. Biomaterials 85:18\u201329. doi: 10.1016\/j.biomaterials.2016.01.048","journal-title":"Biomaterials"},{"issue":"11","key":"8552_CR66","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.joca.2015.07.004","volume":"23","author":"YM Pers","year":"2015","unstructured":"Pers YM, Ruiz M, Noel D, Jorgensen C (2015) Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthr Cartil 23(11):2027\u20132035. doi: 10.1016\/j.joca.2015.07.004","journal-title":"Osteoarthr Cartil"},{"issue":"12","key":"8552_CR67","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/j.biochi.2013.04.017","volume":"95","author":"M Maumus","year":"2013","unstructured":"Maumus M, Jorgensen C, Noel D (2013) Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie 95(12):2229\u20132234. doi: 10.1016\/j.biochi.2013.04.017","journal-title":"Biochimie"},{"issue":"1","key":"8552_CR68","doi-asserted-by":"publisher","first-page":"e0114962","DOI":"10.1371\/journal.pone.0114962","volume":"10","author":"K Toupet","year":"2015","unstructured":"Toupet K, Maumus M, Luz-Crawford P, Lombardo E, Lopez-Belmonte J, van Lent P, Garin MI, van den Berg W, Dalemans W, Jorgensen C, Noel D (2015) Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis. PLoS One 10(1):e0114962. doi: 10.1371\/journal.pone.0114962","journal-title":"PLoS One"},{"issue":"7","key":"8552_CR69","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/art.37960","volume":"65","author":"K Toupet","year":"2013","unstructured":"Toupet K, Maumus M, Peyrafitte JA, Bourin P, van Lent PL, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noel D (2013) Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice. Arthritis Rheum 65(7):1786\u20131794. doi: 10.1002\/art.37960","journal-title":"Arthritis Rheum"},{"key":"8552_CR70","doi-asserted-by":"crossref","unstructured":"Maria A, Toupet K, Bony C, Pirot N, Vozenin M-C, Benoit P, Roger P, Batteux F, Le Quellec A, Jorgensen C, Guilpain P, No\u00ebl D (2016) Anti-fibrotic, anti-oxidant and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis. Arthritis Rheum 68:1013\u20131025","DOI":"10.1002\/art.39477"},{"issue":"1","key":"8552_CR71","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1634\/stemcells.2006-0243","volume":"25","author":"TE Meyerrose","year":"2007","unstructured":"Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta JA (2007) In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25(1):220\u2013227. doi: 10.1634\/stemcells.2006-0243","journal-title":"Stem Cells"},{"issue":"1","key":"8552_CR72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000047856","volume":"169","author":"J Gao","year":"2001","unstructured":"Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI (2001) The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169(1):12\u201320","journal-title":"Cells Tissues Organs"},{"issue":"5","key":"8552_CR73","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18(5):683\u2013692. doi: 10.1089\/scd.2008.0253","journal-title":"Stem Cells Dev"},{"issue":"1","key":"8552_CR74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2353\/ajpath.2009.080629","volume":"175","author":"Y Moodley","year":"2009","unstructured":"Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A (2009) Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175(1):303\u2013313. doi: 10.2353\/ajpath.2009.080629","journal-title":"Am J Pathol"},{"issue":"2","key":"8552_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/scd.2008.0019","volume":"18","author":"D Wolf","year":"2009","unstructured":"Wolf D, Reinhard A, Seckinger A, Katus HA, Kuecherer H, Hansen A (2009) Dose-dependent effects of intravenous allogeneic mesenchymal stem cells in the infarcted porcine heart. Stem Cells Dev 18(2):321\u2013329. doi: 10.1089\/scd.2008.0019","journal-title":"Stem Cells Dev"},{"issue":"3","key":"8552_CR76","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/14653240903502712","volume":"12","author":"SY Joo","year":"2010","unstructured":"Joo SY, Cho KA, Jung YJ, Kim HS, Park SY, Choi YB, Hong KM, Woo SY, Seoh JY, Cho SJ, Ryu KH (2010) Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner. Cytotherapy 12(3):361\u2013370. doi: 10.3109\/14653240903502712","journal-title":"Cytotherapy"},{"issue":"1","key":"8552_CR77","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/ar4156","volume":"15","author":"G Desando","year":"2013","unstructured":"Desando G, Cavallo C, Sartoni F, Martini L, Parrilli A, Veronesi F, Fini M, Giardino R, Facchini A, Grigolo B (2013) Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model. Arthritis Res Ther 15(1):R22. doi: 10.1186\/ar4156","journal-title":"Arthritis Res Ther"},{"key":"8552_CR78","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/emm.2013.94","volume":"45","author":"MB Murphy","year":"2013","unstructured":"Murphy MB, Moncivais K, Caplan AI (2013) Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 45:e54. doi: 10.1038\/emm.2013.94","journal-title":"Exp Mol Med"},{"issue":"5","key":"8552_CR79","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Blanc Le","year":"2012","unstructured":"Le Blanc K, Mougiakakos D (2012) Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 12(5):383\u2013396. doi: 10.1038\/nri3209","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"8552_CR80","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","volume":"107","author":"GM Spaggiari","year":"2006","unstructured":"Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107(4):1484\u20131490. doi: 10.1182\/blood-2005-07-2775","journal-title":"Blood"},{"issue":"6","key":"8552_CR81","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","volume":"108","author":"AJ Nauta","year":"2006","unstructured":"Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE (2006) Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108(6):2114\u20132120. doi: 10.1182\/blood-2005-11-011650","journal-title":"Blood"},{"issue":"10","key":"8552_CR82","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3727\/096368910X564076","volume":"20","author":"MJ Crop","year":"2011","unstructured":"Crop MJ, Korevaar SS, de Kuiper R, IJzermans JN, van Besouw NM, Baan CC, Weimar W, Hoogduijn MJ (2011) Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells. Cell Transplant 20(10):1547\u20131559. doi: 10.3727\/096368910X564076","journal-title":"Cell Transplant"},{"issue":"4","key":"8552_CR83","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000343078","volume":"85","author":"R Lim","year":"2013","unstructured":"Lim R, Milton P, Murphy SV, Dickinson H, Chan ST, Jenkin G (2013) Human mesenchymal stem cells reduce lung injury in immunocompromised mice but not in immunocompetent mice. Respiration 85(4):332\u2013341. doi: 10.1159\/000343078","journal-title":"Respiration"},{"issue":"4","key":"8552_CR84","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2006-12-063412","volume":"110","author":"M Breitbach","year":"2007","unstructured":"Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JW, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SE, Fleischmann BK (2007) Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110(4):1362\u20131369. doi: 10.1182\/blood-2006-12-063412","journal-title":"Blood"},{"issue":"10","key":"8552_CR85","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/kep162","volume":"48","author":"C Bouffi","year":"2009","unstructured":"Bouffi C, Djouad F, Mathieu M, Noel D, Jorgensen C (2009) Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology (Oxford) 48(10):1185\u20131189. doi: 10.1093\/rheumatology\/kep162","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"8552_CR86","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1158\/0008-5472.CAN-08-3562","volume":"69","author":"PJ Mishra","year":"2009","unstructured":"Mishra PJ, Mishra PJ, Glod JW, Banerjee D (2009) Mesenchymal stem cells: flip side of the coin. Cancer Res 69(4):1255\u20131258. doi: 10.1158\/0008-5472.CAN-08-3562","journal-title":"Cancer Res"},{"issue":"4","key":"8552_CR87","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1634\/stemcells.2005-0403","volume":"24","author":"M Miura","year":"2006","unstructured":"Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, Chen W, Ried T, Shi S (2006) Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24(4):1095\u20131103. doi: 10.1634\/stemcells.2005-0403","journal-title":"Stem Cells"},{"issue":"2","key":"8552_CR88","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","volume":"25","author":"J Tolar","year":"2007","unstructured":"Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE, Blazar BR (2007) Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25(2):371\u2013379. doi: 10.1634\/stemcells.2005-0620","journal-title":"Stem Cells"},{"issue":"8","key":"8552_CR89","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","volume":"115","author":"K Tarte","year":"2010","unstructured":"Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Tchirkov A, Rouard H, Henry C, Splingard M, Dulong J, Monnier D, Gourmelon P, Gorin NC, Sensebe L, Societe Francaise de Greffe de Moelle et Therapie C (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115(8):1549\u20131553. doi: 10.1182\/blood-2009-05-219907","journal-title":"Blood"},{"issue":"19","key":"8552_CR90","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","volume":"67","author":"ME Bernardo","year":"2007","unstructured":"Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montagna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67(19):9142\u20139149. doi: 10.1158\/0008-5472.CAN-06-4690","journal-title":"Cancer Res"},{"issue":"8","key":"8552_CR91","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/01.tp.0000236098.13804.0b","volume":"82","author":"F Djouad","year":"2006","unstructured":"Djouad F, Bony C, Apparailly F, Louis-Plence P, Jorgensen C, Noel D (2006) Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 82(8):1060\u20131066. doi: 10.1097\/01.tp.0000236098.13804.0b","journal-title":"Transplantation"},{"issue":"10","key":"8552_CR92","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials G (2012) Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 7(10):e47559. doi: 10.1371\/journal.pone.0047559","journal-title":"PLoS One"},{"issue":"Pt 11","key":"8552_CR93","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L Silva Meirelles da","year":"2006","unstructured":"da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(Pt 11):2204\u20132213. doi: 10.1242\/jcs.02932","journal-title":"J Cell Sci"},{"issue":"2","key":"8552_CR94","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cellimm.2010.06.006","volume":"264","author":"M Najar","year":"2010","unstructured":"Najar M, Raicevic G, Boufker HI, Fayyad Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L (2010) Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton\u2019s Jelly and bone marrow sources. Cell Immunol 264(2):171\u2013179. doi: 10.1016\/j.cellimm.2010.06.006","journal-title":"Cell Immunol"},{"issue":"2","key":"8552_CR95","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/14653240802582075","volume":"11","author":"JJ Montesinos","year":"2009","unstructured":"Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, Flores-Guzman P, Hernandez-Estevez E, Fajardo-Orduna G, Orozco S, Mayani H (2009) Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 11(2):163\u2013176. doi: 10.1080\/14653240802582075","journal-title":"Cytotherapy"},{"key":"8552_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2244","author":"P Luz-Crawford","year":"2015","unstructured":"Luz-Crawford P, Torres MJ, Noel D, Fernandez A, Toupet K, Alcayaga-Miranda F, Tejedor G, Jorgensen C, Illanes SE, Figueroa FE, Djouad F, Khoury M (2015) The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases. Stem Cells. doi: 10.1002\/stem.2244","journal-title":"Stem Cells"},{"issue":"9","key":"8552_CR97","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1634\/stemcells.2008-0304","volume":"26","author":"N Kaltz","year":"2008","unstructured":"Kaltz N, Funari A, Hippauf S, Delorme B, Noel D, Riminucci M, Jacobs VR, Haupl T, Jorgensen C, Charbord P, Peschel C, Bianco P, Oostendorp RA (2008) In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells 26(9):2419\u20132424. doi: 10.1634\/stemcells.2008-0304","journal-title":"Stem Cells"},{"issue":"1","key":"8552_CR98","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cyto.a.22402","volume":"85","author":"BR Sousa","year":"2014","unstructured":"Sousa BR, Parreira RC, Fonseca EA, Amaya MJ, Tonelli FM, Lacerda SM, Lalwani P, Santos AK, Gomes KN, Ulrich H, Kihara AH, Resende RR (2014) Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications. Cytometry A 85(1):43\u201377. doi: 10.1002\/cyto.a.22402","journal-title":"Cytometry A"},{"issue":"3","key":"8552_CR99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000071150","volume":"174","author":"DA Ugarte De","year":"2003","unstructured":"De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH (2003) Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174(3):101\u2013109","journal-title":"Cells Tissues Organs"},{"issue":"2","key":"8552_CR100","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pmic.200800035","volume":"9","author":"S Roche","year":"2009","unstructured":"Roche S, Delorme B, Oostendorp RA, Barbet R, Caton D, Noel D, Boumediene K, Papadaki HA, Cousin B, Crozet C, Milhavet O, Casteilla L, Hatzfeld J, Jorgensen C, Charbord P, Lehmann S (2009) Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 9(2):223\u2013232. doi: 10.1002\/pmic.200800035","journal-title":"Proteomics"},{"key":"8552_CR101","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1749-6632.2012.06551.x","volume":"1266","author":"K Sivasubramaniyan","year":"2012","unstructured":"Sivasubramaniyan K, Lehnen D, Ghazanfari R, Sobiesiak M, Harichandan A, Mortha E, Petkova N, Grimm S, Cerabona F, de Zwart P, Abele H, Aicher WK, Faul C, Kanz L, Buhring HJ (2012) Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. Ann N Y Acad Sci 1266:94\u2013106. doi: 10.1111\/j.1749-6632.2012.06551.x","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"8552_CR102","doi-asserted-by":"publisher","first-page":"R1304","DOI":"10.1186\/ar1827","volume":"7","author":"F Djouad","year":"2005","unstructured":"Djouad F, Bony C, Haupl T, Uze G, Lahlou N, Louis-Plence P, Apparailly F, Canovas F, Reme T, Sany J, Jorgensen C, Noel D (2005) Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7(6):R1304\u2013R1315. doi: 10.1186\/ar1827","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"8552_CR103","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jcyt.2012.11.005","volume":"15","author":"DG Phinney","year":"2013","unstructured":"Phinney DG, Sensebe L (2013) Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy 15(2):140\u2013145. doi: 10.1016\/j.jcyt.2012.11.005","journal-title":"Cytotherapy"},{"issue":"5","key":"8552_CR104","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3727\/096368910X536473","volume":"20","author":"T Deuse","year":"2011","unstructured":"Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S (2011) Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20(5):655\u2013667. doi: 10.3727\/096368910X536473","journal-title":"Cell Transplant"},{"issue":"19","key":"8552_CR105","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1089\/scd.2013.0016","volume":"22","author":"H Wegmeyer","year":"2013","unstructured":"Wegmeyer H, Broske AM, Leddin M, Kuentzer K, Nisslbeck AK, Hupfeld J, Wiechmann K, Kuhlen J, von Schwerin C, Stein C, Knothe S, Funk J, Huss R, Neubauer M (2013) Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev 22(19):2606\u20132618. doi: 10.1089\/scd.2013.0016","journal-title":"Stem Cells Dev"},{"issue":"7","key":"8552_CR106","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.yexcr.2007.12.022","volume":"314","author":"D Noel","year":"2008","unstructured":"Noel D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, Jorgensen C, Cousin B (2008) Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 314(7):1575\u20131584. doi: 10.1016\/j.yexcr.2007.12.022","journal-title":"Exp Cell Res"},{"issue":"1","key":"8552_CR107","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","volume":"129","author":"B Puissant","year":"2005","unstructured":"Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, Blancher A (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129(1):118\u2013129. doi: 10.1111\/j.1365-2141.2005.05409.x","journal-title":"Br J Haematol"},{"issue":"14","key":"8552_CR108","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1089\/scd.2011.0722","volume":"21","author":"M Strioga","year":"2012","unstructured":"Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J (2012) Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 21(14):2724\u20132752. doi: 10.1089\/scd.2011.0722","journal-title":"Stem Cells Dev"},{"key":"8552_CR109","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-015-0246-3","volume":"6","author":"MK Gupta","year":"2015","unstructured":"Gupta MK, Ajay AK (2015) Fat on sale: role of adipose-derived stem cells as anti-fibrosis agent in regenerative medicine. Stem Cell Res Ther 6:233. doi: 10.1186\/s13287-015-0246-3","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"8552_CR110","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1517\/14712598.2013.823153","volume":"13","author":"M Pikula","year":"2013","unstructured":"Pikula M, Marek-Trzonkowska N, Wardowska A, Renkielska A, Trzonkowski P (2013) Adipose tissue-derived stem cells in clinical applications. Expert Opin Biol Ther 13(10):1357\u20131370. doi: 10.1517\/14712598.2013.823153","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"8552_CR111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/14653240801982979","volume":"10","author":"K Lin","year":"2008","unstructured":"Lin K, Matsubara Y, Masuda Y, Togashi K, Ohno T, Tamura T, Toyoshima Y, Sugimachi K, Toyoda M, Marc H, Douglas A (2008) Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 10(4):417\u2013426. doi: 10.1080\/14653240801982979","journal-title":"Cytotherapy"},{"issue":"2","key":"8552_CR112","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/scrt19","volume":"1","author":"JM Gimble","year":"2010","unstructured":"Gimble JM, Guilak F, Bunnell BA (2010) Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 1(2):19. doi: 10.1186\/scrt19","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"8552_CR113","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/157488810791268555","volume":"5","author":"AM Bailey","year":"2010","unstructured":"Bailey AM, Kapur S, Katz AJ (2010) Characterization of adipose-derived stem cells: an update. Curr Stem Cell Res Ther 5(2):95\u2013102","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"8552_CR114","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2014.01.002","volume":"2","author":"WK Ong","year":"2014","unstructured":"Ong WK, Tan CS, Chan KL, Goesantoso GG, Chan XH, Chan E, Yin J, Yeo CR, Khoo CM, So JB, Shabbir A, Toh SA, Han W, Sugii S (2014) Identification of specific cell-surface markers of adipose-derived stem cells from subcutaneous and visceral fat depots. Stem Cell Rep 2(2):171\u2013179. doi: 10.1016\/j.stemcr.2014.01.002","journal-title":"Stem Cell Rep"},{"key":"8552_CR115","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fimmu.2015.00655","volume":"6","author":"C Bony","year":"2015","unstructured":"Bony C, Cren M, Domergue S, Toupet K, Jorgensen C, Noel D (2015) Adipose mesenchymal stem cells isolated after manual or water-jet-assisted liposuction display similar properties. Front Immunol 6:655. doi: 10.3389\/fimmu.2015.00655","journal-title":"Front Immunol"},{"issue":"4","key":"8552_CR116","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cellbi.2007.12.007","volume":"32","author":"I Bochev","year":"2008","unstructured":"Bochev I, Elmadjian G, Kyurkchiev D, Tzvetanov L, Altankova I, Tivchev P, Kyurkchiev S (2008) Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 32(4):384\u2013393. doi: 10.1016\/j.cellbi.2007.12.007","journal-title":"Cell Biol Int"},{"issue":"1\u20132","key":"8552_CR117","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.imlet.2009.07.010","volume":"126","author":"E Ivanova-Todorova","year":"2009","unstructured":"Ivanova-Todorova E, Bochev I, Mourdjeva M, Dimitrov R, Bukarev D, Kyurkchiev S, Tivchev P, Altunkova I, Kyurkchiev DS (2009) Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol Lett 126(1\u20132):37\u201342. doi: 10.1016\/j.imlet.2009.07.010","journal-title":"Immunol Lett"},{"issue":"10","key":"8552_CR118","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","volume":"109","author":"J Rehman","year":"2004","unstructured":"Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109(10):1292\u20131298. doi: 10.1161\/01.CIR.0000121425.42966.F1","journal-title":"Circulation"},{"issue":"2","key":"8552_CR119","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jdermsci.2007.08.004","volume":"49","author":"WS Kim","year":"2008","unstructured":"Kim WS, Park BS, Kim HK, Park JS, Kim KJ, Choi JS, Chung SJ, Kim DD, Sung JH (2008) Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 49(2):133\u2013142. doi: 10.1016\/j.jdermsci.2007.08.004","journal-title":"J Dermatol Sci"},{"issue":"7","key":"8552_CR120","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1517\/14712590903039684","volume":"9","author":"WS Kim","year":"2009","unstructured":"Kim WS, Park BS, Sung JH (2009) The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 9(7):879\u2013887. doi: 10.1517\/14712590903039684","journal-title":"Expert Opin Biol Ther"},{"issue":"4\u20135","key":"8552_CR121","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.autrev.2014.01.052","volume":"13","author":"C Chang","year":"2014","unstructured":"Chang C (2014) Unmet needs in the treatment of autoimmunity: from aspirin to stem cells. Autoimmun Rev 13(4\u20135):331\u2013346. doi: 10.1016\/j.autrev.2014.01.052","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8552_CR122","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/0961203309361482","volume":"19","author":"Y Nie","year":"2010","unstructured":"Nie Y, Lau C, Lie A, Chan G, Mok M (2010) Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 19(7):850\u2013859. doi: 10.1177\/0961203309361482","journal-title":"Lupus"},{"issue":"6","key":"8552_CR123","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/ard.2007.076174","volume":"67","author":"MC Kastrinaki","year":"2008","unstructured":"Kastrinaki MC, Sidiropoulos P, Roche S, Ringe J, Lehmann S, Kritikos H, Vlahava VM, Delorme B, Eliopoulos GD, Jorgensen C, Charbord P, Haupl T, Boumpas DT, Papadaki HA (2008) Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis 67(6):741\u2013749. doi: 10.1136\/ard.2007.076174","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8552_CR124","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","volume":"16","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Campese AF, Liakouli V, Carubbi F, Pantano I, Berardicurt O, Screpanti I, Giacomelli R (2014) Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther 16(5):442. doi: 10.1186\/s13075-014-0442-z","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8552_CR125","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10456-013-9338-9","volume":"16","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Marrelli A, Benedetto PD, Liakouli V, Carubbi F, Ruscitti P, Alvaro S, Pantano I, Campese AF, Grazioli P, Screpanti I, Giacomelli R (2013) Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine. Angiogenesis 16(3):595\u2013607. doi: 10.1007\/s10456-013-9338-9","journal-title":"Angiogenesis"},{"issue":"1","key":"8552_CR126","first-page":"211","volume":"27","author":"M Orciani","year":"2013","unstructured":"Orciani M, Svegliati S, Gorbi S, Spadoni T, Lazzarini R, Regoli F, Di Primio R, Gabrielli A (2013) Alterations of ROS pathways in scleroderma begin at stem cell level. J Biol Regul Homeost Agents 27(1):211\u2013224","journal-title":"J Biol Regul Homeost Agents"},{"issue":"12","key":"8552_CR127","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1089\/10430340152480258","volume":"12","author":"A Bartholomew","year":"2001","unstructured":"Bartholomew A, Patil S, Mackay A, Nelson M, Buyaner D, Hardy W, Mosca J, Sturgeon C, Siatskas M, Mahmud N, Ferrer K, Deans R, Moseley A, Hoffman R, Devine SM (2001) Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther 12(12):1527\u20131541. doi: 10.1089\/10430340152480258","journal-title":"Hum Gene Ther"},{"issue":"5","key":"8552_CR128","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106(5):1755\u20131761. doi: 10.1182\/blood-2005-04-1496","journal-title":"Blood"},{"issue":"4","key":"8552_CR129","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/art.22511","volume":"56","author":"A Augello","year":"2007","unstructured":"Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G (2007) Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56(4):1175\u20131186. doi: 10.1002\/art.22511","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8552_CR130","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1136\/ard.2010.143297","volume":"70","author":"C Bouffi","year":"2011","unstructured":"Bouffi C, Bony C, Jorgensen C, Noel D (2011) Skin fibroblasts are potent suppressors of inflammation in experimental arthritis. Ann Rheum Dis 70(9):1671\u20131676. doi: 10.1136\/ard.2010.143297","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8552_CR131","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/cmi.2008.52","volume":"5","author":"K Zhou","year":"2008","unstructured":"Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, Sun L (2008) Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice. Cell Mol Immunol 5(6):417\u2013424. doi: 10.1038\/cmi.2008.52","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"8552_CR132","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","volume":"81","author":"O Ringden","year":"2006","unstructured":"Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81(10):1390\u20131397. doi: 10.1097\/01.tp.0000214462.63943.14","journal-title":"Transplantation"},{"issue":"46","key":"8552_CR133","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","volume":"103","author":"RH Lee","year":"2006","unstructured":"Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice. Proc Natl Acad Sci U S A 103(46):17438\u201317443. doi: 10.1073\/pnas.0608249103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"8552_CR134","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/eji.200738129","volume":"38","author":"D Polchert","year":"2008","unstructured":"Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, Genrich K, Mehrotra S, Setty S, Smith B, Bartholomew A (2008) IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 38(6):1745\u20131755. doi: 10.1002\/eji.200738129","journal-title":"Eur J Immunol"},{"issue":"2","key":"8552_CR135","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","volume":"12","author":"AT Borchers","year":"2012","unstructured":"Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME (2012) Lupus nephritis: a critical review. Autoimmun Rev 12(2):174\u2013194. doi: 10.1016\/j.autrev.2012.08.018","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8552_CR136","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.autrev.2013.11.007","volume":"13","author":"R Cervera","year":"2014","unstructured":"Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F, Maurel F, Garofano A, Roset M, Perna A, Murray M, Schmitt C, Boucot I (2014) Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev 13(6):621\u2013629. doi: 10.1016\/j.autrev.2013.11.007","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8552_CR137","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1385\/CRIAI:23:3:247","volume":"23","author":"P Riboldi","year":"2002","unstructured":"Riboldi P, Gerosa M, Luzzana C, Catelli L (2002) Cardiac involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 23(3):247\u2013261. doi: 10.1385\/CRIAI:23:3:247","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"8552_CR138","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.autrev.2008.08.004","volume":"8","author":"S Sitia","year":"2009","unstructured":"Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S, Carerj S, Turiel M (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8(4):281\u2013286. doi: 10.1016\/j.autrev.2008.08.004","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8552_CR139","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","volume":"15","author":"GC Wu","year":"2016","unstructured":"Wu GC, Liu HR, Leng RX, Li XP, Li XM, Pan HF, Ye DQ (2016) Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis. Autoimmun Rev 15(1):22\u201337. doi: 10.1016\/j.autrev.2015.10.002","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8552_CR140","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.autrev.2015.11.012","volume":"15","author":"J Qian","year":"2016","unstructured":"Qian J, Wang Y, Huang C, Yang X, Zhao J, Wang Q, Tian Z, Li M, Zeng X (2016) Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: a PRISMA-compliant systematic review and meta-analysis. Autoimmun Rev 15(3):250\u2013257. doi: 10.1016\/j.autrev.2015.11.012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8552_CR141","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.autrev.2014.11.001","volume":"14","author":"N Sarbu","year":"2015","unstructured":"Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, Yousry T, Capurro S, Jager R, Cervera R, Bargallo N (2015) Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev 14(2):153\u2013159. doi: 10.1016\/j.autrev.2014.11.001","journal-title":"Autoimmun Rev"},{"issue":"12","key":"8552_CR142","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.autrev.2015.07.017","volume":"14","author":"D Roccatello","year":"2015","unstructured":"Roccatello D, Sciascia S, Baldovino S, Rossi D, Alpa M, Naretto C, Di Simone D, Simoncini M, Menegatti E (2015) A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment\u2014clinical response compared to literature and immunological re-assessment. Autoimmun Rev 14(12):1123\u20131130. doi: 10.1016\/j.autrev.2015.07.017","journal-title":"Autoimmun Rev"},{"issue":"9","key":"8552_CR143","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.autrev.2014.08.015","volume":"13","author":"H Jeltsch-David","year":"2014","unstructured":"Jeltsch-David H, Muller S (2014) Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. Autoimmun Rev 13(9):963\u2013973. doi: 10.1016\/j.autrev.2014.08.015","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8552_CR144","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.autrev.2012.09.003","volume":"12","author":"M Gatto","year":"2013","unstructured":"Gatto M, Zen M, Ghirardello A, Bettio S, Bassi N, Iaccarino L, Punzi L, Doria A (2013) Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 12(4):523\u2013536. doi: 10.1016\/j.autrev.2012.09.003","journal-title":"Autoimmun Rev"},{"issue":"9","key":"8552_CR145","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.autrev.2011.09.008","volume":"11","author":"P Sawla","year":"2012","unstructured":"Sawla P, Hossain A, Hahn BH, Singh RP (2012) Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance. Autoimmun Rev 11(9):611\u2013614. doi: 10.1016\/j.autrev.2011.09.008","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8552_CR146","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2015.05.011","volume":"14","author":"I Ruiz-Arruza","year":"2015","unstructured":"Ruiz-Arruza I, Barbosa C, Ugarte A, Ruiz-Irastorza G (2015) Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis. Autoimmun Rev 14(10):875\u2013879. doi: 10.1016\/j.autrev.2015.05.011","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8552_CR147","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2015.09.006","volume":"15","author":"J Hannah","year":"2016","unstructured":"Hannah J, Casian A, D\u2019Cruz D (2016) Tacrolimus use in lupus nephritis: a systematic review and meta-analysis. Autoimmun Rev 15(1):93\u2013101. doi: 10.1016\/j.autrev.2015.09.006","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8552_CR148","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2015.08.007","volume":"15","author":"M Frieri","year":"2016","unstructured":"Frieri M, Stampfl H (2016) Systemic lupus erythematosus and atherosclerosis: review of the literature. Autoimmun Rev 15(1):16\u201321. doi: 10.1016\/j.autrev.2015.08.007","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8552_CR149","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1568-9972(03)00083-1","volume":"3","author":"Y Cohen","year":"2004","unstructured":"Cohen Y, Nagler A (2004) Treatment of refractory autoimmune diseases with ablative immunotherapy. Autoimmun Rev 3(2):21\u201329. doi: 10.1016\/S1568-9972(03)00083-1","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8552_CR150","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.autrev.2012.03.009","volume":"12","author":"S Sciascia","year":"2012","unstructured":"Sciascia S, Ceberio L, Garcia-Fernandez C, Roccatello D, Karim Y, Cuadrado MJ (2012) Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. Autoimmun Rev 12(2):157\u2013163. doi: 10.1016\/j.autrev.2012.03.009","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8552_CR151","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/0961203313483376","volume":"22","author":"RJ Davies","year":"2013","unstructured":"Davies RJ, Sangle SR, Jordan NP, Aslam L, Lewis MJ, Wedgwood R, D\u2019Cruz DP (2013) Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis. Lupus 22(6):574\u2013582. doi: 10.1177\/0961203313483376","journal-title":"Lupus"},{"issue":"11","key":"8552_CR152","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.autrev.2014.08.020","volume":"13","author":"A Kamal","year":"2014","unstructured":"Kamal A, Khamashta M (2014) The efficacy of novel B cell biologics as the future of SLE treatment: a review. Autoimmun Rev 13(11):1094\u20131101. doi: 10.1016\/j.autrev.2014.08.020","journal-title":"Autoimmun Rev"},{"issue":"12","key":"8552_CR153","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/art.30613","volume":"63","author":"R Furie","year":"2011","unstructured":"Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzova D, Sanchez-Guerrero J, Schwarting A, Merrill JT, Chatham WW, Stohl W, Ginzler EM, Hough DR, Zhong ZJ, Freimuth W, van Vollenhoven RF, Group B-S (2011) A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum 63(12):3918\u20133930. doi: 10.1002\/art.30613","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8552_CR154","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.autrev.2014.10.001","volume":"14","author":"J Liao","year":"2015","unstructured":"Liao J, Chang C, Wu H, Lu Q (2015) Cell-based therapies for systemic lupus erythematosus. Autoimmun Rev 14(1):43\u201348. doi: 10.1016\/j.autrev.2014.10.001","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8552_CR155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.2001.03076.x","volume":"115","author":"HA Papadaki","year":"2001","unstructured":"Papadaki HA, Boumpas DT, Gibson FM, Jayne DR, Axford JS, Gordon-Smith EC, Marsh JC, Eliopoulos GD (2001) Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 115(1):167\u2013174","journal-title":"Br J Haematol"},{"issue":"6","key":"8552_CR156","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","volume":"27","author":"L Sun","year":"2009","unstructured":"Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6):1421\u20131432. doi: 10.1002\/stem.68","journal-title":"Stem Cells"},{"issue":"2","key":"8552_CR157","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0961203306075793","volume":"16","author":"LY Sun","year":"2007","unstructured":"Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM (2007) Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 16(2):121\u2013128","journal-title":"Lupus"},{"key":"8552_CR158","doi-asserted-by":"publisher","first-page":"826182","DOI":"10.1155\/2012\/826182","volume":"2012","author":"Y Tang","year":"2012","unstructured":"Tang Y, Ma X, Zhang H, Gu Z, Hou Y, Gilkeson GS, Lu L, Zeng X, Sun L (2012) Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clin Dev Immunol 2012:826182. doi: 10.1155\/2012\/826182","journal-title":"Clin Dev Immunol"},{"issue":"12","key":"8552_CR159","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.cellsig.2012.07.012","volume":"24","author":"Z Gu","year":"2012","unstructured":"Gu Z, Cao X, Jiang J, Li L, Da Z, Liu H, Cheng C (2012) Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients. Cell Signal 24(12):2307\u20132314. doi: 10.1016\/j.cellsig.2012.07.012","journal-title":"Cell Signal"},{"issue":"1\u20132","key":"8552_CR160","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11010-013-1866-5","volume":"387","author":"Z Gu","year":"2014","unstructured":"Gu Z, Tan W, Feng G, Meng Y, Shen B, Liu H, Cheng C (2014) Wnt\/beta-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53\/p21 pathway. Mol Cell Biochem 387(1\u20132):27\u201337. doi: 10.1007\/s11010-013-1866-5","journal-title":"Mol Cell Biochem"},{"issue":"13","key":"8552_CR161","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1089\/scd.2011.0447","volume":"21","author":"X Li","year":"2012","unstructured":"Li X, Liu L, Meng D, Wang D, Zhang J, Shi D, Liu H, Xu H, Lu L, Sun L (2012) Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Stem Cells Dev 21(13):2387\u20132394. doi: 10.1089\/scd.2011.0447","journal-title":"Stem Cells Dev"},{"issue":"2","key":"8552_CR162","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clim.2012.08.012","volume":"145","author":"F Gu","year":"2012","unstructured":"Gu F, Molano I, Ruiz P, Sun L, Gilkeson GS (2012) Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL\/lpr and (NZB\/NZW)F1 mice. Clin Immunol 145(2):142\u2013152. doi: 10.1016\/j.clim.2012.08.012","journal-title":"Clin Immunol"},{"issue":"9","key":"8552_CR163","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.4049\/jimmunol.1401636","volume":"193","author":"E Collins","year":"2014","unstructured":"Collins E, Gu F, Qi M, Molano I, Ruiz P, Sun L, Gilkeson GS (2014) Differential efficacy of human mesenchymal stem cells based on source of origin. J Immunol 193(9):4381\u20134390. doi: 10.4049\/jimmunol.1401636","journal-title":"J Immunol"},{"issue":"12","key":"8552_CR164","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3727\/096368912X658692","volume":"22","author":"X Ma","year":"2013","unstructured":"Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, Hou Y, Gilkeson G, Lu L, Sun L (2013) Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant 22(12):2279\u20132290. doi: 10.3727\/096368912X658692","journal-title":"Cell Transplant"},{"issue":"1","key":"8552_CR165","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2249.2010.04158.x","volume":"161","author":"M Youd","year":"2010","unstructured":"Youd M, Blickarz C, Woodworth L, Touzjian T, Edling A, Tedstone J, Ruzek M, Tubo R, Kaplan J, Lodie T (2010) Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin Exp Immunol 161(1):176\u2013186. doi: 10.1111\/j.1365-2249.2010.04158.x","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"8552_CR166","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/art.27560","volume":"62","author":"F Schena","year":"2010","unstructured":"Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, Casazza S, Uccelli A, Moretta L, Martini A, Traggiai E (2010) Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum 62(9):2776\u20132786. doi: 10.1002\/art.27560","journal-title":"Arthritis Rheum"},{"issue":"11","key":"8552_CR167","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3727\/096368914X685645","volume":"24","author":"MJ Park","year":"2015","unstructured":"Park MJ, Kwok SK, Lee SH, Kim EK, Park SH, Cho ML (2015) Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus. Cell Transplant 24(11):2367\u20132377. doi: 10.3727\/096368914X685645","journal-title":"Cell Transplant"},{"issue":"17","key":"8552_CR168","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1089\/scd.2015.0021","volume":"24","author":"EW Choi","year":"2015","unstructured":"Choi EW, Shin IS, Song JW, Yun TW, Yang J, Choi KS, Seong JK (2015) Transplantation of adipose tissue-derived mesenchymal stem cells prevents the development of lupus dermatitis. Stem Cells Dev 24(17):2041\u20132051. doi: 10.1089\/scd.2015.0021","journal-title":"Stem Cells Dev"},{"key":"8552_CR169","doi-asserted-by":"publisher","DOI":"10.3727\/096368915X689442","author":"EW Choi","year":"2015","unstructured":"Choi EW, Lee HW, Shin S, Park JH, Yun TW, Youn HY, Kim SJ (2015) Comparative efficacies of long-term serial transplantation of syngeneic, allogeneic, xenogeneic, or CTLA4Ig overproducing xenogeneic adipose tissue-derived mesenchymal stem cells on murine systemic lupus erythematosus. Cell Transplant. doi: 10.3727\/096368915X689442","journal-title":"Cell Transplant"},{"issue":"1","key":"8552_CR170","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/art.33313","volume":"64","author":"EW Choi","year":"2012","unstructured":"Choi EW, Shin IS, Park SY, Park JH, Kim JS, Yoon EJ, Kang SK, Ra JC, Hong SH (2012) Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum 64(1):243\u2013253. doi: 10.1002\/art.33313","journal-title":"Arthritis Rheum"},{"issue":"13","key":"8552_CR171","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1177\/0961203310373782","volume":"19","author":"Z Gu","year":"2010","unstructured":"Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, Hou Y, Lu L, Gilkeson GS, Silver RM, Zeng X, Shi S, Sun L (2010) Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL\/lpr mice. Lupus 19(13):1502\u20131514. doi: 10.1177\/0961203310373782","journal-title":"Lupus"},{"issue":"2","key":"8552_CR172","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3727\/096368910X520056","volume":"20","author":"JW Chang","year":"2011","unstructured":"Chang JW, Hung SP, Wu HH, Wu WM, Yang AH, Tsai HL, Yang LY, Lee OK (2011) Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant 20(2):245\u2013257. doi: 10.3727\/096368910X520056","journal-title":"Cell Transplant"},{"issue":"3","key":"8552_CR173","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0961203309348983","volume":"19","author":"F Carrion","year":"2010","unstructured":"Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, Monckeberg G, Figueroa FE (2010) Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 19(3):317\u2013322. doi: 10.1177\/0961203309348983","journal-title":"Lupus"},{"issue":"8","key":"8552_CR174","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, Hou Y, Zeng X, Gilkeson GS, Sun L (2010) Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69(8):1423\u20131429. doi: 10.1136\/ard.2009.123463","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8552_CR175","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, Lu L, Shi S (2010) Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62(8):2467\u20132475. doi: 10.1002\/art.27548","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8552_CR176","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/bmt.2012.184","volume":"48","author":"X Li","year":"2013","unstructured":"Li X, Wang D, Liang J, Zhang H, Sun L (2013) Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus. Bone Marrow Transplant 48(4):544\u2013550. doi: 10.1038\/bmt.2012.184","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"8552_CR177","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nrrheum.2010.80","volume":"6","author":"J Liang","year":"2010","unstructured":"Liang J, Gu F, Wang H, Hua B, Hou Y, Shi S, Lu L, Sun L (2010) Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 6(8):486\u2013489. doi: 10.1038\/nrrheum.2010.80","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"8552_CR178","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10067-012-1943-2","volume":"31","author":"D Shi","year":"2012","unstructured":"Shi D, Wang D, Li X, Zhang H, Che N, Lu Z, Sun L (2012) Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus. Clin Rheumatol 31(5):841\u2013846. doi: 10.1007\/s10067-012-1943-2","journal-title":"Clin Rheumatol"},{"issue":"12","key":"8552_CR179","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3727\/096368911X582769","volume":"22","author":"D Wang","year":"2013","unstructured":"Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, Hua B, Liu B, Lu L, Gilkeson GS, Silver RM, Chen W, Shi S, Sun L (2013) Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant 22(12):2267\u20132277. doi: 10.3727\/096368911X582769","journal-title":"Cell Transplant"},{"issue":"11","key":"8552_CR180","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","volume":"33","author":"F Gu","year":"2014","unstructured":"Gu F, Wang D, Zhang H, Feng X, Gilkeson GS, Shi S, Sun L (2014) Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol 33(11):1611\u20131619. doi: 10.1007\/s10067-014-2754-4","journal-title":"Clin Rheumatol"},{"issue":"2","key":"8552_CR181","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/ar4520","volume":"16","author":"D Wang","year":"2014","unstructured":"Wang D, Li J, Zhang Y, Zhang M, Chen J, Li X, Hu X, Jiang S, Shi S, Sun L (2014) Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res Ther 16(2):R79. doi: 10.1186\/ar4520","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"8552_CR182","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.autrev.2012.11.009","volume":"12","author":"V Modena","year":"2013","unstructured":"Modena V, Bianchi G, Roccatello D (2013) Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target? Autoimmun Rev 12(8):835\u2013838. doi: 10.1016\/j.autrev.2012.11.009","journal-title":"Autoimmun Rev"},{"issue":"8","key":"8552_CR183","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.autrev.2012.11.010","volume":"12","author":"OM Epis","year":"2013","unstructured":"Epis OM, Giacomelli L, Deidda S, Bruschi E (2013) Tight control applied to the biological therapy of rheumatoid arthritis. Autoimmun Rev 12(8):839\u2013841. doi: 10.1016\/j.autrev.2012.11.010","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8552_CR184","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","volume":"12","author":"T Dimitroulas","year":"2013","unstructured":"Dimitroulas T, Nikas SN, Trontzas P, Kitas GD (2013) Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmun Rev 12(10):958\u2013966. doi: 10.1016\/j.autrev.2013.03.015","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8552_CR185","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.autrev.2013.01.001","volume":"12","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Nadler SG (2013) Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis. Autoimmun Rev 12(7):758\u2013767. doi: 10.1016\/j.autrev.2013.01.001","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8552_CR186","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2249.2009.04069.x","volume":"159","author":"B Chen","year":"2010","unstructured":"Chen B, Hu J, Liao L, Sun Z, Han Q, Song Z, Zhao RC (2010) Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin Exp Immunol 159(3):292\u2013302. doi: 10.1111\/j.1365-2249.2009.04069.x","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"8552_CR187","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.21012","volume":"52","author":"F Djouad","year":"2005","unstructured":"Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D (2005) Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 52(5):1595\u20131603. doi: 10.1002\/art.21012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8552_CR188","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1186\/ar3187","volume":"12","author":"Y Liu","year":"2010","unstructured":"Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z (2010) Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 12(6):R210. doi: 10.1186\/ar3187","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8552_CR189","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/art.24405","volume":"60","author":"MA Gonzalez","year":"2009","unstructured":"Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60(4):1006\u20131019. doi: 10.1002\/art.24405","journal-title":"Arthritis Rheum"},{"issue":"24","key":"8552_CR190","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1089\/scd.2013.0023","volume":"22","author":"L Wang","year":"2013","unstructured":"Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H, Zhu D, Wu M, Liu Y (2013) Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev 22(24):3192\u20133202. doi: 10.1089\/scd.2013.0023","journal-title":"Stem Cells Dev"},{"key":"8552_CR191","doi-asserted-by":"publisher","first-page":"9165267","DOI":"10.1155\/2016\/9165267","volume":"2016","author":"L Wang","year":"2016","unstructured":"Wang L, Zhang Y, Li H, Hong J, Chen X, Li M, Bai W, Wang J, Liu Y, Wu M (2016) Clinical observation of employment of umbilical cord derived mesenchymal stem cell for juvenile idiopathic arthritis therapy. Stem Cells Int 2016:9165267. doi: 10.1155\/2016\/9165267","journal-title":"Stem Cells Int"},{"issue":"3","key":"8552_CR192","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jcyt.2013.10.006","volume":"16","author":"S Khalili","year":"2014","unstructured":"Khalili S, Faustman DL, Liu Y, Sumita Y, Blank D, Peterson A, Kodama S, Tran SD (2014) Treatment for salivary gland hypofunction at both initial and advanced stages of Sjogren-like disease: a comparative study of bone marrow therapy versus spleen cell therapy with a 1-year monitoring period. Cytotherapy 16(3):412\u2013423. doi: 10.1016\/j.jcyt.2013.10.006","journal-title":"Cytotherapy"},{"issue":"15","key":"8552_CR193","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, Ding G, Gao R, Zhang C, Ding Y, Bromberg JS, Chen W, Sun L, Wang S (2012) Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood 120(15):3142\u20133151. doi: 10.1182\/blood-2011-11-391144","journal-title":"Blood"},{"issue":"2","key":"8552_CR194","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12016-012-8347-6","volume":"45","author":"J Voswinkel","year":"2013","unstructured":"Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L, Chapel A (2013) Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin Rev Allergy Immunol 45(2):180\u2013192. doi: 10.1007\/s12016-012-8347-6","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"8552_CR195","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3727\/096368912X656045","volume":"22","author":"YB Cho","year":"2013","unstructured":"Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS (2013) Autologous adipose tissue-derived stem cells for the treatment of Crohn\u2019s fistula: a phase I clinical study. Cell Transplant 22(2):279\u2013285. doi: 10.3727\/096368912X656045","journal-title":"Cell Transplant"},{"issue":"12","key":"8552_CR196","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/gut.2010.215152","volume":"59","author":"M Duijvestein","year":"2010","unstructured":"Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, van den Brink GR, Hommes DW (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn\u2019s disease: results of a phase I study. Gut 59(12):1662\u20131669. doi: 10.1136\/gut.2010.215152","journal-title":"Gut"},{"issue":"3","key":"8552_CR197","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","volume":"28","author":"F Portilla de la","year":"2013","unstructured":"de la Portilla F, Alba F, Garcia-Olmo D, Herrerias JM, Gonzalez FX, Galindo A (2013) Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn\u2019s disease: results from a multicenter phase I\/IIa clinical trial. Int J Color Dis 28(3):313\u2013323. doi: 10.1007\/s00384-012-1581-9","journal-title":"Int J Color Dis"},{"issue":"10","key":"8552_CR198","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.mayocp.2013.06.021","volume":"88","author":"M Gregorini","year":"2013","unstructured":"Gregorini M, Maccario R, Avanzini MA, Corradetti V, Moretta A, Libetta C, Esposito P, Bosio F, Dal Canton A, Rampino T (2013) Antineutrophil cytoplasmic antibody-associated renal vasculitis treated with autologous mesenchymal stromal cells: evaluation of the contribution of immune-mediated mechanisms. Mayo Clin Proc 88(10):1174\u20131179. doi: 10.1016\/j.mayocp.2013.06.021","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"8552_CR199","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/1756-185X.12068","volume":"16","author":"F Davatchi","year":"2013","unstructured":"Davatchi F, Nikbin B, Shams H, Sadeghi Abdollahi B, Mohyeddin M, Shahram F (2013) Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet\u2019s disease retinal vasculitis: report of three patients. Int J Rheum Dis 16(2):139\u2013147. doi: 10.1111\/1756-185X.12068","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"8552_CR200","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2337\/dc15-0094","volume":"38","author":"S Lablanche","year":"2015","unstructured":"Lablanche S, Borot S, Wojtusciszyn A, Bayle F, Tetaz R, Badet L, Thivolet C, Morelon E, Frimat L, Penfornis A, Kessler L, Brault C, Colin C, Tauveron I, Bosco D, Berney T, Benhamou PY, Network G (2015) Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL network. Diabetes Care 38(9):1714\u20131722. doi: 10.2337\/dc15-0094","journal-title":"Diabetes Care"},{"issue":"1","key":"8552_CR201","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2008.10.004","volume":"32","author":"I Boumaza","year":"2009","unstructured":"Boumaza I, Srinivasan S, Witt WT, Feghali-Bostwick C, Dai Y, Garcia-Ocana A, Feili-Hariri M (2009) Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 32(1):33\u201342. doi: 10.1016\/j.jaut.2008.10.004","journal-title":"J Autoimmun"},{"issue":"1","key":"8552_CR202","doi-asserted-by":"publisher","first-page":"e0145838","DOI":"10.1371\/journal.pone.0145838","volume":"11","author":"Y Xin","year":"2016","unstructured":"Xin Y, Jiang X, Wang Y, Su X, Sun M, Zhang L, Tan Y, Wintergerst KA, Li Y, Li Y (2016) Insulin-producing cells differentiated from human bone marrow mesenchymal stem cells in vitro ameliorate streptozotocin-induced diabetic hyperglycemia. PLoS One 11(1):e0145838. doi: 10.1371\/journal.pone.0145838","journal-title":"PLoS One"},{"issue":"3","key":"8552_CR203","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ana.21076","volume":"61","author":"E Gerdoni","year":"2007","unstructured":"Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, Mantegazza R, Frassoni F, Mancardi G, Pedotti R, Uccelli A (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61(3):219\u2013227. doi: 10.1002\/ana.21076","journal-title":"Ann Neurol"},{"issue":"6","key":"8552_CR204","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archneur.65.6.753","volume":"65","author":"I Kassis","year":"2008","unstructured":"Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D (2008) Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65(6):753\u2013761. doi: 10.1001\/archneur.65.6.753","journal-title":"Arch Neurol"},{"key":"8552_CR205","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijdevneu.2016.01.005","volume":"49","author":"D Wang","year":"2016","unstructured":"Wang D, Li SP, Fu JS, Bai L, Guo L (2016) Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Int J Dev Neurosci 49:60\u201366. doi: 10.1016\/j.ijdevneu.2016.01.005","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"8552_CR206","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","volume":"11","author":"P Connick","year":"2012","unstructured":"Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 11(2):150\u2013156. doi: 10.1016\/S1474-4422(11)70305-2","journal-title":"Lancet Neurol"},{"issue":"6","key":"8552_CR207","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","volume":"3","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, Freedman MS, Krupp L, Paulo C, Hariri RJ, Fischkoff SA (2014) Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult Scler Relat Disord 3(6):696\u2013704. doi: 10.1016\/j.msard.2014.08.002","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"8552_CR208","doi-asserted-by":"publisher","first-page":"e113936","DOI":"10.1371\/journal.pone.0113936","volume":"9","author":"S Llufriu","year":"2014","unstructured":"Llufriu S, Sepulveda M, Blanco Y, Marin P, Moreno B, Berenguer J, Gabilondo I, Martinez-Heras E, Sola-Valls N, Arnaiz JA, Andreu EJ, Fernandez B, Bullich S, Sanchez-Dalmau B, Graus F, Villoslada P, Saiz A (2014) Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS One 9(12):e113936. doi: 10.1371\/journal.pone.0113936","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"8552_CR209","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3727\/096368914X685005","volume":"23","author":"JF Li","year":"2014","unstructured":"Li JF, Zhang DJ, Geng T, Chen L, Huang H, Yin HL, Zhang YZ, Lou JY, Cao B, Wang YL (2014) The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis. Cell Transplant 23(Suppl 1):S113\u2013S122. doi: 10.3727\/096368914X685005","journal-title":"Cell Transplant"},{"issue":"9624","key":"8552_CR210","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Blanc Le","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringden O, Developmental Committee of the European Group for B, Marrow T (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371(9624):1579\u20131586. doi: 10.1016\/S0140-6736(08)60690-X","journal-title":"Lancet"},{"issue":"11","key":"8552_CR211","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1634\/stemcells.2006-0228","volume":"24","author":"R Yanez","year":"2006","unstructured":"Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA (2006) Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 24(11):2582\u20132591. doi: 10.1634\/stemcells.2006-0228","journal-title":"Stem Cells"},{"issue":"10","key":"8552_CR212","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1016\/j.transproceed.2007.08.103","volume":"39","author":"B Fang","year":"2007","unstructured":"Fang B, Song Y, Liao L, Zhang Y, Zhao RC (2007) Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 39(10):3358\u20133362. doi: 10.1016\/j.transproceed.2007.08.103","journal-title":"Transplant Proc"},{"issue":"3","key":"8552_CR213","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/eji.200838729","volume":"39","author":"QF Kong","year":"2009","unstructured":"Kong QF, Sun B, Wang GY, Zhai DX, Mu LL, Wang DD, Wang JH, Li R, Li HL (2009) BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. Eur J Immunol 39(3):800\u2013809. doi: 10.1002\/eji.200838729","journal-title":"Eur J Immunol"},{"issue":"1\u20132","key":"8552_CR214","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jneuroim.2008.12.005","volume":"207","author":"QF Kong","year":"2009","unstructured":"Kong QF, Sun B, Bai SS, Zhai DX, Wang GY, Liu YM, Zhang SJ, Li R, Zhao W, Sun YY, Li N, Wang Q, Peng HS, Jin LH, Li HL (2009) Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1\/Th2\/Th17\/Treg cell subsets through the secretion of TGF-beta. J Neuroimmunol 207(1\u20132):83\u201391. doi: 10.1016\/j.jneuroim.2008.12.005","journal-title":"J Neuroimmunol"},{"issue":"3","key":"8552_CR215","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1365-3083.2010.02445.x","volume":"72","author":"J Yu","year":"2010","unstructured":"Yu J, Zheng C, Ren X, Li J, Liu M, Zhang L, Liang L, Du W, Han ZC (2010) Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action. Scand J Immunol 72(3):242\u2013249. doi: 10.1111\/j.1365-3083.2010.02445.x","journal-title":"Scand J Immunol"},{"issue":"1","key":"8552_CR216","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.autrev.2010.06.002","volume":"11","author":"KP Tiev","year":"2011","unstructured":"Tiev KP, Cabane J (2011) Digestive tract involvement in systemic sclerosis. Autoimmun Rev 11(1):68\u201373. doi: 10.1016\/j.autrev.2010.06.002","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8552_CR217","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","volume":"10","author":"C Chizzolini","year":"2011","unstructured":"Chizzolini C, Brembilla NC, Montanari E, Truchetet ME (2011) Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 10(5):276\u2013281. doi: 10.1016\/j.autrev.2010.09.016","journal-title":"Autoimmun Rev"},{"issue":"11","key":"8552_CR218","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.autrev.2011.04.025","volume":"10","author":"I Almeida","year":"2011","unstructured":"Almeida I, Faria R, Vita P, Vasconcelos C (2011) Systemic sclerosis refractory disease: from the skin to the heart. Autoimmun Rev 10(11):693\u2013701. doi: 10.1016\/j.autrev.2011.04.025","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8552_CR219","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.autrev.2010.09.008","volume":"10","author":"F Galluccio","year":"2011","unstructured":"Galluccio F, Matucci-Cerinic M (2011) Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis. Autoimmun Rev 10(5):241\u2013243. doi: 10.1016\/j.autrev.2010.09.008","journal-title":"Autoimmun Rev"},{"issue":"8","key":"8552_CR220","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.autrev.2006.12.006","volume":"6","author":"S Guiducci","year":"2007","unstructured":"Guiducci S, Giacomelli R, Cerinic MM (2007) Vascular complications of scleroderma. Autoimmun Rev 6(8):520\u2013523. doi: 10.1016\/j.autrev.2006.12.006","journal-title":"Autoimmun Rev"},{"issue":"11","key":"8552_CR221","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.autrev.2010.06.006","volume":"9","author":"S Lambova","year":"2010","unstructured":"Lambova S, Muller-Ladner U (2010) Pulmonary arterial hypertension in systemic sclerosis. Autoimmun Rev 9(11):761\u2013770. doi: 10.1016\/j.autrev.2010.06.006","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8552_CR222","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.autrev.2014.12.001","volume":"14","author":"I Chora","year":"2015","unstructured":"Chora I, Guiducci S, Manetti M, Romano E, Mazzotta C, Bellando-Randone S, Ibba-Manneschi L, Matucci-Cerinic M, Soares R (2015) Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis. Autoimmun Rev 14(4):314\u2013322. doi: 10.1016\/j.autrev.2014.12.001","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8552_CR223","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.autrev.2010.09.014","volume":"10","author":"U Nussinovitch","year":"2011","unstructured":"Nussinovitch U, Shoenfeld Y (2011) Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev 10(5):259\u2013266. doi: 10.1016\/j.autrev.2010.09.014","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8552_CR224","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","volume":"10","author":"J Baraut","year":"2010","unstructured":"Baraut J, Michel L, Verrecchia F, Farge D (2010) Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 10(2):65\u201373. doi: 10.1016\/j.autrev.2010.08.003","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8552_CR225","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.autrev.2011.04.013","volume":"10","author":"S Bosello","year":"2011","unstructured":"Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, Ferraccioli G (2011) B cells in systemic sclerosis: a possible target for therapy. Autoimmun Rev 10(10):624\u2013630. doi: 10.1016\/j.autrev.2011.04.013","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8552_CR226","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","volume":"12","author":"S Mehra","year":"2013","unstructured":"Mehra S, Walker J, Patterson K, Fritzler MJ (2013) Autoantibodies in systemic sclerosis. Autoimmun Rev 12(3):340\u2013354. doi: 10.1016\/j.autrev.2012.05.011","journal-title":"Autoimmun Rev"},{"issue":"8","key":"8552_CR227","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.autrev.2009.02.018","volume":"8","author":"T Czompoly","year":"2009","unstructured":"Czompoly T, Simon D, Czirjak L, Nemeth P (2009) Anti-topoisomerase I autoantibodies in systemic sclerosis. Autoimmun Rev 8(8):692\u2013696. doi: 10.1016\/j.autrev.2009.02.018","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8552_CR228","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.autrev.2015.10.001","volume":"15","author":"F Perosa","year":"2016","unstructured":"Perosa F, Prete M, Di Lernia G, Ostuni C, Favoino E, Valentini G (2016) Anti-centromere protein A antibodies in systemic sclerosis: significance and origin. Autoimmun Rev 15(1):102\u2013109. doi: 10.1016\/j.autrev.2015.10.001","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8552_CR229","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.autrev.2009.02.002","volume":"8","author":"I Cavazzana","year":"2009","unstructured":"Cavazzana I, Ceribelli A, Airo P, Zingarelli S, Tincani A, Franceschini F (2009) Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression. Autoimmun Rev 8(7):580\u2013584. doi: 10.1016\/j.autrev.2009.02.002","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8552_CR230","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","volume":"40","author":"E Hachulla","year":"2011","unstructured":"Hachulla E, Launay D (2011) Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 40(2):78\u201383. doi: 10.1007\/s12016-010-8198-y","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"8552_CR231","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.autrev.2015.07.012","volume":"14","author":"C Almeida","year":"2015","unstructured":"Almeida C, Almeida I, Vasconcelos C (2015) Quality of life in systemic sclerosis. Autoimmun Rev 14(12):1087\u20131096. doi: 10.1016\/j.autrev.2015.07.012","journal-title":"Autoimmun Rev"},{"issue":"12","key":"8552_CR232","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.autrev.2015.07.016","volume":"14","author":"C Bruni","year":"2015","unstructured":"Bruni C, Raja J, Denton CP, Matucci-Cerinic M (2015) The clinical relevance of sexual dysfunction in systemic sclerosis. Autoimmun Rev 14(12):1111\u20131115. doi: 10.1016\/j.autrev.2015.07.016","journal-title":"Autoimmun Rev"},{"issue":"Suppl 3","key":"8552_CR233","doi-asserted-by":"publisher","first-page":"iii40","DOI":"10.1093\/rheumatology\/kep109","volume":"48","author":"AU Wells","year":"2009","unstructured":"Wells AU, Steen V, Valentini G (2009) Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology (Oxford) 48(Suppl 3):iii40\u2013iii44. doi: 10.1093\/rheumatology\/kep109","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"8552_CR234","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.autrev.2010.09.012","volume":"10","author":"G Bussone","year":"2011","unstructured":"Bussone G, Mouthon L (2011) Interstitial lung disease in systemic sclerosis. Autoimmun Rev 10(5):248\u2013255. doi: 10.1016\/j.autrev.2010.09.012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8552_CR235","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12016-009-8191-5","volume":"40","author":"L Mouthon","year":"2011","unstructured":"Mouthon L, Berezne A, Bussone G, Noel LH, Villiger PM, Guillevin L (2011) Scleroderma renal crisis: a rare but severe complication of systemic sclerosis. Clin Rev Allergy Immunol 40(2):84\u201391. doi: 10.1007\/s12016-009-8191-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"8552_CR236","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.autrev.2003.11.004","volume":"3","author":"PE Carreira","year":"2004","unstructured":"Carreira PE (2004) Pulmonary hypertension in autoimmune rheumatic diseases. Autoimmun Rev 3(4):313\u2013320. doi: 10.1016\/j.autrev.2003.11.004","journal-title":"Autoimmun Rev"},{"key":"8552_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.01.016","author":"G Murdaca","year":"2016","unstructured":"Murdaca G, Contatore M, Gulli R, Mandich P, Puppo F (2016) Genetic factors and systemic sclerosis. Autoimmun Rev. doi: 10.1016\/j.autrev.2016.01.016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8552_CR238","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.autrev.2010.09.017","volume":"10","author":"P Dieude","year":"2011","unstructured":"Dieude P, Boileau C, Allanore Y (2011) Immunogenetics of systemic sclerosis. Autoimmun Rev 10(5):282\u2013290. doi: 10.1016\/j.autrev.2010.09.017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8552_CR239","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","volume":"13","author":"I Marie","year":"2014","unstructured":"Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noel D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13(2):151\u2013156. doi: 10.1016\/j.autrev.2013.10.002","journal-title":"Autoimmun Rev"},{"key":"8552_CR240","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2015.07.005","volume":"64","author":"L Bossini-Castillo","year":"2015","unstructured":"Bossini-Castillo L, Lopez-Isac E, Martin J (2015) Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun 64:53\u201365. doi: 10.1016\/j.jaut.2015.07.005","journal-title":"J Autoimmun"},{"issue":"5","key":"8552_CR241","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","volume":"10","author":"J Wei","year":"2011","unstructured":"Wei J, Bhattacharyya S, Tourtellotte WG, Varga J (2011) Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 10(5):267\u2013275. doi: 10.1016\/j.autrev.2010.09.015","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8552_CR242","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","volume":"10","author":"P Cipriani","year":"2011","unstructured":"Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R (2011) Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev 10(10):641\u2013646. doi: 10.1016\/j.autrev.2011.04.016","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8552_CR243","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","volume":"10","author":"V Liakouli","year":"2011","unstructured":"Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10(10):590\u2013594. doi: 10.1016\/j.autrev.2011.04.019","journal-title":"Autoimmun Rev"},{"issue":"9","key":"8552_CR244","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/ard.2006.067504","volume":"66","author":"A Servettaz","year":"2007","unstructured":"Servettaz A, Guilpain P, Goulvestre C, Chereau C, Hercend C, Nicco C, Guillevin L, Weill B, Mouthon L, Batteux F (2007) Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann Rheum Dis 66(9):1202\u20131209. doi: 10.1136\/ard.2006.067504","journal-title":"Ann Rheum Dis"},{"issue":"10 Pt 2","key":"8552_CR245","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/j.lpm.2014.01.020","volume":"43","author":"D Launay","year":"2014","unstructured":"Launay D, Savale L, Berezne A, Le Pavec J, Hachulla E, Mouthon L, Sitbon O, Lambert B, Gaudric M, Jais X, Stephan F, Hatron PY, Lamblin N, Vignaux O, Cottin V, Farge D, Wallaert B, Guillevin L, Simonneau G, Mercier O, Fadel E, Dartevelle P, Humbert M, Mussot S, Working Group on Heart\/Lung transplantation in systemic sclerosis of the French Network on Pulmonary H (2014) Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. Presse Med 43(10 Pt 2):e345\u2013e363. doi: 10.1016\/j.lpm.2014.01.020","journal-title":"Presse Med"},{"issue":"2","key":"8552_CR246","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11926-015-0560-x","volume":"18","author":"V Sobanski","year":"2016","unstructured":"Sobanski V, Launay D, Hachulla E, Humbert M (2016) Current approaches to the treatment of systemic-sclerosis-associated pulmonary arterial hypertension (SSc-PAH). Curr Rheumatol Rep 18(2):10. doi: 10.1007\/s11926-015-0560-x","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"8552_CR247","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","volume":"51","author":"M Elhai","year":"2012","unstructured":"Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51(6):1017\u20131026. doi: 10.1093\/rheumatology\/ker269","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8552_CR248","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/ard.2007.071464","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, Larghero J, Gluckman E, Preijers FW, van Dijk AP, Bax JJ, Roblot P, van Riel PL, van Laar JM, Farge D (2008) Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 67(1):98\u2013104. doi: 10.1136\/ard.2007.071464","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8552_CR249","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","volume":"60","author":"M Binks","year":"2001","unstructured":"Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, Kotter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A (2001) Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 60(6):577\u2013584","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"8552_CR250","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM Laar van","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kotter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quere I, Rich E, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socie G, Gratwohl A, Tyndall A, Group EESS (2014) Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 311(24):2490\u20132498. doi: 10.1001\/jama.2014.6368","journal-title":"JAMA"},{"issue":"3","key":"8552_CR251","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2141.2002.03895.x","volume":"119","author":"D Farge","year":"2002","unstructured":"Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, Hachulla E, Philippe P, Sibilia J, Rabian C, Chevret S, Gluckman E, Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes Study G (2002) Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study. Br J Haematol 119(3):726\u2013739","journal-title":"Br J Haematol"},{"issue":"8","key":"8552_CR252","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/ard.2003.011205","volume":"63","author":"D Farge","year":"2004","unstructured":"Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, Peter HH, Breedveld FC, Fibbe WE, Black C, Denton C, Koetter I, Locatelli F, Martini A, Schattenberg AV, van den Hoogen F, van de Putte L, Lanza F, Arnold R, Bacon PA, Bingham S, Ciceri F, Didier B, Diez-Martin JL, Emery P, Feremans W, Hertenstein B, Hiepe F, Luosujarvi R, Leon Lara A, Marmont A, Martinez AM, Pascual Cascon H, Bocelli-Tyndall C, Gluckman E, Gratwohl A, Tyndall A, EE Registry (2004) Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR Registry. Ann Rheum Dis 63(8):974\u2013981. doi: 10.1136\/ard.2003.011205","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8552_CR253","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/rheumatology\/kev117","volume":"54","author":"JM Laar van","year":"2015","unstructured":"van Laar JM, Naraghi K, Tyndall A (2015) Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis. Rheumatology 54(12):2126\u20132133. doi: 10.1093\/rheumatology\/kev117","journal-title":"Rheumatology"},{"key":"8552_CR254","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/asheducation-2011.1.280","volume":"2011","author":"A Tyndall","year":"2011","unstructured":"Tyndall A (2011) Successes and failures of stem cell transplantation in autoimmune diseases. Hematology \/ Educ Program Am Soc Hematol Am Soc Hemat Educ Program 2011:280\u2013284. doi: 10.1182\/asheducation-2011.1.280","journal-title":"Hematology \/ Educ Program Am Soc Hematol Am Soc Hemat Educ Program"},{"issue":"2","key":"8552_CR255","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrrheum.2013.166","volume":"10","author":"A Tyndall","year":"2014","unstructured":"Tyndall A (2014) Mesenchymal stem cell treatments in rheumatology: a glass half full? Nat Rev Rheumatol 10(2):117\u2013124. doi: 10.1038\/nrrheum.2013.166","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"8552_CR256","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/ard.2007.071233","volume":"67","author":"J Larghero","year":"2008","unstructured":"Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Fois E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C (2008) Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann Rheum Dis 67(4):443\u2013449. doi: 10.1136\/ard.2007.071233","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8552_CR257","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","volume":"46","author":"C Bocelli-Tyndall","year":"2007","unstructured":"Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A (2007) Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) 46(3):403\u2013408. doi: 10.1093\/rheumatology\/kel267","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"8552_CR258","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/art.22035","volume":"54","author":"N Papa Del","year":"2006","unstructured":"Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, Maglione W, Comina DP, Vitali C, Fraticelli P, Gabrielli A, Cortelezzi A, Lambertenghi-Deliliers G (2006) Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 54(8):2605\u20132615. doi: 10.1002\/art.22035","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8552_CR259","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/art.22698","volume":"56","author":"P Cipriani","year":"2007","unstructured":"Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, Dolo V, Pavan A, Saccardi R, Tyndall A, Giacomelli R, Cerinic MM (2007) Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 56(6):1994\u20132004. doi: 10.1002\/art.22698","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8552_CR260","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/cei.12111","volume":"173","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Di Benedetto P, Liakouli V, Del Papa B, Di Padova M, Di Ianni M, Marrelli A, Alesse E, Giacomelli R (2013) Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. Clin Exp Immunol 173(2):195\u2013206. doi: 10.1111\/cei.12111","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"8552_CR261","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1136\/ard.2011.150607","volume":"70","author":"S Guiducci","year":"2011","unstructured":"Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML, Saccardi R, Ibba-Manneschi L, Matucci-Cerinic M (2011) Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis 70(11):2011\u20132021. doi: 10.1136\/ard.2011.150607","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8552_CR262","doi-asserted-by":"publisher","first-page":"e001890","DOI":"10.1136\/bmjopen-2012-001890","volume":"3","author":"V Vanneaux","year":"2013","unstructured":"Vanneaux V, Farge-Bancel D, Lecourt S, Baraut J, Cras A, Jean-Louis F, Brun C, Verrecchia F, Larghero J, Michel L (2013) Expression of transforming growth factor beta receptor II in mesenchymal stem cells from systemic sclerosis patients. BMJ Open 3(1):e001890. doi: 10.1136\/bmjopen-2012-001890","journal-title":"BMJ Open"},{"issue":"5","key":"8552_CR263","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3727\/096368912X639017","volume":"22","author":"N Scuderi","year":"2013","unstructured":"Scuderi N, Ceccarelli S, Onesti MG, Fioramonti P, Guidi C, Romano F, Frati L, Angeloni A, Marchese C (2013) Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant 22(5):779\u2013795. doi: 10.3727\/096368912X639017","journal-title":"Cell Transplant"},{"issue":"6","key":"8552_CR264","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/BOR.0b013e32834b1606","volume":"23","author":"F Batteux","year":"2011","unstructured":"Batteux F, Kavian N, Servettaz A (2011) New insights on chemically induced animal models of systemic sclerosis. Curr Opin Rheumatol 23(6):511\u2013518. doi: 10.1097\/BOR.0b013e32834b1606","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"8552_CR265","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/01902148.2013.816803","volume":"39","author":"AC Inamdar","year":"2013","unstructured":"Inamdar AC, Inamdar AA (2013) Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell. Exp Lung Res 39(8):315\u2013327. doi: 10.3109\/01902148.2013.816803","journal-title":"Exp Lung Res"},{"issue":"2","key":"8552_CR266","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1165\/rcmb.2004-0330OC","volume":"33","author":"M Rojas","year":"2005","unstructured":"Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33(2):145\u2013152. doi: 10.1165\/rcmb.2004-0330OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"8552_CR267","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1183\/09031936.00128508","volume":"34","author":"M Kumamoto","year":"2009","unstructured":"Kumamoto M, Nishiwaki T, Matsuo N, Kimura H, Matsushima K (2009) Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 34(3):740\u2013748. doi: 10.1183\/09031936.00128508","journal-title":"Eur Respir J"},{"issue":"4","key":"8552_CR268","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3727\/096368909788809857","volume":"18","author":"A Cargnoni","year":"2009","unstructured":"Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, Arienti D, Lombardi G, Albertini A, Wengler GS, Parolini O (2009) Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18(4):405\u2013422. doi: 10.3727\/096368909788809857","journal-title":"Cell Transplant"},{"issue":"26","key":"8552_CR269","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1073\/pnas.0704421104","volume":"104","author":"LA Ortiz","year":"2007","unstructured":"Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104(26):11002\u201311007. doi: 10.1073\/pnas.0704421104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8552_CR270","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1):54\u201363. doi: 10.1016\/j.stem.2009.05.003","journal-title":"Cell Stem Cell"},{"key":"8552_CR271","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1465-9921-11-16","volume":"11","author":"SH Lee","year":"2010","unstructured":"Lee SH, Jang AS, Kim YE, Cha JY, Kim TH, Jung S, Park SK, Lee YK, Won JH, Kim YH, Park CS (2010) Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury\/fibrosis. Respir Res 11:16. doi: 10.1186\/1465-9921-11-16","journal-title":"Respir Res"},{"issue":"6","key":"8552_CR272","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000348831","volume":"197","author":"M Conese","year":"2013","unstructured":"Conese M, Carbone A, Castellani S, Di Gioia S (2013) Paracrine effects and heterogeneity of marrow-derived stem\/progenitor cells: relevance for the treatment of respiratory diseases. Cells Tissues Organs 197(6):445\u2013473. doi: 10.1159\/000348831","journal-title":"Cells Tissues Organs"},{"issue":"9","key":"8552_CR273","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","volume":"182","author":"A Servettaz","year":"2009","unstructured":"Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chereau C, Vuiblet V, Guillevin L, Mouthon L, Weill B, Batteux F (2009) Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 182(9):5855\u20135864. doi: 10.4049\/jimmunol.0803705","journal-title":"J Immunol"},{"issue":"3","key":"8552_CR274","doi-asserted-by":"publisher","first-page":"036007","DOI":"10.1088\/1752-7155\/9\/3\/036007","volume":"9","author":"T Hua-Huy","year":"2015","unstructured":"Hua-Huy T, Le-Dong NN, Duong-Quy S, Bei Y, Riviere S, Tiev KP, Nicco C, Chereau C, Batteux F, Dinh-Xuan AT (2015) Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis. J Breath Res 9(3):036007. doi: 10.1088\/1752-7155\/9\/3\/036007","journal-title":"J Breath Res"},{"issue":"10","key":"8552_CR275","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1002\/art.34534","volume":"64","author":"N Kavian","year":"2012","unstructured":"Kavian N, Marut W, Servettaz A, Nicco C, Chereau C, Lemarechal H, Borderie D, Dupin N, Weill B, Batteux F (2012) Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis. Arthritis Rheum 64(10):3430\u20133440. doi: 10.1002\/art.34534","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8552_CR276","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/art.34354","volume":"64","author":"N Kavian","year":"2012","unstructured":"Kavian N, Servettaz A, Marut W, Nicco C, Chereau C, Weill B, Batteux F (2012) Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor beta in the skin of mice with scleroderma-like features and prevents the development of the disease. Arthritis Rheum 64(6):1990\u20132000. doi: 10.1002\/art.34354","journal-title":"Arthritis Rheum"},{"issue":"11","key":"8552_CR277","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1002\/art.27626","volume":"62","author":"N Kavian","year":"2010","unstructured":"Kavian N, Servettaz A, Mongaret C, Wang A, Nicco C, Chereau C, Grange P, Vuiblet V, Birembaut P, Diebold MD, Weill B, Dupin N, Batteux F (2010) Targeting ADAM-17\/notch signaling abrogates the development of systemic sclerosis in a murine model. Arthritis Rheum 62(11):3477\u20133487. doi: 10.1002\/art.27626","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8552_CR278","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/ar4351","volume":"15","author":"W Marut","year":"2013","unstructured":"Marut W, Jamier V, Kavian N, Servettaz A, Winyard PG, Eggleton P, Anwar A, Nicco C, Jacob C, Chereau C, Weill B, Batteux F (2013) The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse. Arthritis Res Ther 15(5):R167. doi: 10.1186\/ar4351","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"8552_CR279","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/art.37873","volume":"65","author":"W Marut","year":"2013","unstructured":"Marut W, Kavian N, Servettaz A, Hua-Huy T, Nicco C, Chereau C, Weill B, Dinh-Xuan AT, Batteux F (2013) Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade. Arthritis Rheum 65(5):1367\u20131377. doi: 10.1002\/art.37873","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8552_CR280","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/jid.2011.455","volume":"132","author":"WK Marut","year":"2012","unstructured":"Marut WK, Kavian N, Servettaz A, Nicco C, Ba LA, Doering M, Chereau C, Jacob C, Weill B, Batteux F (2012) The organotelluride catalyst (PHTE)(2)NQ prevents HOCl-induced systemic sclerosis in mouse. J Invest Dermatol 132(4):1125\u20131132. doi: 10.1038\/jid.2011.455","journal-title":"J Invest Dermatol"},{"issue":"1","key":"8552_CR281","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2353\/ajpath.2010.090763","volume":"177","author":"A Servettaz","year":"2010","unstructured":"Servettaz A, Kavian N, Nicco C, Deveaux V, Chereau C, Wang A, Zimmer A, Lotersztajn S, Weill B, Batteux F (2010) Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis. Am J Pathol 177(1):187\u2013196. doi: 10.2353\/ajpath.2010.090763","journal-title":"Am J Pathol"},{"issue":"5","key":"8552_CR282","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar4300","volume":"15","author":"G Bagnato","year":"2013","unstructured":"Bagnato G, Bitto A, Irrera N, Pizzino G, Sangari D, Cinquegrani M, Roberts W, Atteritano M, Altavilla D, Squadrito F, Bagnato G, Saitta A (2013) Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis. Arthritis Res Ther 15(5):R120. doi: 10.1186\/ar4300","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"8552_CR283","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/rheumatology\/ket144","volume":"52","author":"G Bagnato","year":"2013","unstructured":"Bagnato G, Bitto A, Pizzino G, Irrera N, Sangari D, Cinquegrani M, Roberts WN, Matucci Cerinic M, Squadrito F, Altavilla D, Bagnato G, Saitta A (2013) Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis. Rheumatology 52(8):1377\u20131386. doi: 10.1093\/rheumatology\/ket144","journal-title":"Rheumatology"},{"key":"8552_CR284","doi-asserted-by":"crossref","unstructured":"Maria A, Toupet K, Maumus M, Fonteneau G, Le Quellec A, Jorgensen C, Guilpain P, No\u00ebl D (2016) Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis. J Autoimmunity 70:31\u201339","DOI":"10.1016\/j.jaut.2016.03.013"},{"key":"8552_CR285","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12569","author":"N Naderi","year":"2016","unstructured":"Naderi N, Combellack EJ, Griffin M, Sedaghati T, Javed M, Findlay MW, Wallace CG, Mosahebi A, Butler PE, Seifalian AM, Whitaker IS (2016) The regenerative role of adipose-derived stem cells (ADSC) in plastic and reconstructive surgery. Int Wound J. doi: 10.1111\/iwj.12569","journal-title":"Int Wound J"},{"issue":"5","key":"8552_CR286","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2217\/17460751.2.5.785","volume":"2","author":"JJ Lataillade","year":"2007","unstructured":"Lataillade JJ, Doucet C, Bey E, Carsin H, Huet C, Clairand I, Bottollier-Depois JF, Chapel A, Ernou I, Gourven M, Boutin L, Hayden A, Carcamo C, Buglova E, Joussemet M, de Revel T, Gourmelon P (2007) New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2(5):785\u2013794. doi: 10.2217\/17460751.2.5.785","journal-title":"Regen Med"},{"issue":"1","key":"8552_CR287","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1524-475X.2009.00562.x","volume":"18","author":"E Bey","year":"2010","unstructured":"Bey E, Prat M, Duhamel P, Benderitter M, Brachet M, Trompier F, Battaglini P, Ernou I, Boutin L, Gourven M, Tissedre F, Crea S, Mansour CA, de Revel T, Carsin H, Gourmelon P, Lataillade JJ (2010) Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen 18(1):50\u201358. doi: 10.1111\/j.1524-475X.2009.00562.x","journal-title":"Wound Repair Regen"},{"issue":"Suppl 1","key":"8552_CR288","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-2184.2010.00727.x","volume":"44","author":"T Leclerc","year":"2011","unstructured":"Leclerc T, Thepenier C, Jault P, Bey E, Peltzer J, Trouillas M, Duhamel P, Bargues L, Prat M, Bonderriter M, Lataillade JJ (2011) Cell therapy of burns. Cell Prolif 44(Suppl 1):48\u201354. doi: 10.1111\/j.1365-2184.2010.00727.x","journal-title":"Cell Prolif"},{"issue":"11","key":"8552_CR289","doi-asserted-by":"publisher","first-page":"916","DOI":"10.5966\/sctm.2013-0030","volume":"2","author":"C Linard","year":"2013","unstructured":"Linard C, Busson E, Holler V, Strup-Perrot C, Lacave-Lapalun JV, Lhomme B, Prat M, Devauchelle P, Sabourin JC, Simon JM, Bonneau M, Lataillade JJ, Benderitter M (2013) Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs. Stem Cells Transl Med 2(11):916\u2013927. doi: 10.5966\/sctm.2013-0030","journal-title":"Stem Cells Transl Med"},{"issue":"10","key":"8552_CR290","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1089\/scd.2014.0486","volume":"24","author":"C Linard","year":"2015","unstructured":"Linard C, Tissedre F, Busson E, Holler V, Leclerc T, Strup-Perrot C, Couty L, L\u2019Homme B, Benderitter M, Lafont A, Lataillade JJ, Coulomb B (2015) Therapeutic potential of gingival fibroblasts for cutaneous radiation syndrome: comparison to bone marrow-mesenchymal stem cell grafts. Stem Cells Dev 24(10):1182\u20131193. doi: 10.1089\/scd.2014.0486","journal-title":"Stem Cells Dev"},{"issue":"5","key":"8552_CR291","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","volume":"22","author":"M Christopeit","year":"2008","unstructured":"Christopeit M, Schendel M, Foll J, Muller LP, Keysser G, Behre G (2008) Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 22(5):1062\u20131064. doi: 10.1038\/sj.leu.2404996","journal-title":"Leukemia"},{"issue":"8","key":"8552_CR292","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/art.30431","volume":"63","author":"G Keyszer","year":"2011","unstructured":"Keyszer G, Christopeit M, Fick S, Schendel M, Taute BM, Behre G, Muller LP, Schmoll HJ (2011) Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases. Arthritis Rheum 63(8):2540\u20132542. doi: 10.1002\/art.30431","journal-title":"Arthritis Rheum"},{"issue":"10","key":"8552_CR293","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","volume":"153","author":"S Guiducci","year":"2010","unstructured":"Guiducci S, Porta F, Saccardi R, Guidi S, Ibba-Manneschi L, Manetti M, Mazzanti B, Dal Pozzo S, Milia AF, Bellando-Randone S, Miniati I, Fiori G, Fontana R, Amanzi L, Braschi F, Bosi A, Matucci-Cerinic M (2010) Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. Ann Intern Med 153(10):650\u2013654. doi: 10.7326\/0003-4819-153-10-201011160-00007","journal-title":"Ann Intern Med"},{"issue":"12","key":"8552_CR294","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","volume":"74","author":"B Granel","year":"2015","unstructured":"Granel B, Daumas A, Jouve E, Harle JR, Nguyen PS, Chabannon C, Colavolpe N, Reynier JC, Truillet R, Mallet S, Baiada A, Casanova D, Giraudo L, Arnaud L, Veran J, Sabatier F, Magalon G (2015) Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis 74(12):2175\u20132182. doi: 10.1136\/annrheumdis-2014-205681","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-016-8552-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8552-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:49:02Z","timestamp":1559425742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-016-8552-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":294,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["8552"],"URL":"https:\/\/doi.org\/10.1007\/s12016-016-8552-9","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]}}}